Publications and communications of Vincent BOURS

Grentzinger, V., Durkin, K. W., Gonon Rodrigues Palmeira, L., Artesi, M., Olivier, S., & Bours, V. (24 November 2023). Identification of novel haplotypes within the challenging medically relevant FLG gene [Poster presentation]. SFMBBM PhD Day, Liège, Belgium.

Kremer, C., Torneri, A., Libin, P. J. K., Meex, C., Hayette, M.-P., Bontems, S., Durkin, K. W., Artesi, M., Bours, V., Lemey, P., Darcis, G., Hens, N., & Meuris, C. (16 June 2023). Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data. Epidemics, 44, 100701. doi:10.1016/j.epidem.2023.100701

Grentzinger, V., GRISART, B., Meynsbrughen, M., Artesi, M., Gonon Rodrigues Palmeira, L., Dideberg, V., CHARLOTEAUX, B., Durkin, K. W., Brysse, A., & Bours, V. (25 May 2023). Detecting pathogenic variants in chronic kidney disease using long-read sequencing [Paper presentation]. Annual Meeting @ Living Tomorrow Vilvoorde, Vilvoorde, Belgium.

Hoogstrate, Y., Draaisma, K., Ghisai, S. A., van Hijfte, L., Barin, N., de Heer, I., Coppieters, W., van den Bosch, T. P. P., Bolleboom, A., Gao, Z., Vincent, A. J. P. E., Karim, L., Deckers, M., Taphoorn, M. J. B., Kerkhof, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukacova, S., ... French, P. J. (10 April 2023). Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell, 41 (4), 678 - 692.e7. doi:10.1016/j.ccell.2023.02.019

Poulet, C., Swingland, J. T., Botta, V., Robe, P., Herens, C., Turkheimer, F., & Bours, V. (2023). Assessment of the normal cell contamination impact on tumour samples analysed with SNP arrays: The signal confusion nightmare. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/302224. doi:10.1101/2023.04.04.534870

Poulet, C.* , Debit, A.* , Josse, C., Jerusalem, G., Azencott, C.-A., Bours, V., & Van Steen, K. (2023). Assessing Random Forest self-reproducibility for optimal short biomarker signature discovery. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/303314. doi:10.1101/2023.03.29.534695
* These authors have contributed equally to this work.

Harvengt, J., Lumaka, A., Fasquelle, C., CABERG, J.-H., Mastouri, M., JANSSEN, A., Gonon Rodrigues Palmeira, L., & Bours, V. (22 March 2023). HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome. Frontiers in Genetics, 14, 1137767. doi:10.3389/fgene.2023.1137767

Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866
* These authors have contributed equally to this work.

Gennigens, C., Denys, H., Altintas, S., Kerger, J., Baurain, J.-F., Bours, V., Henry, S., Van De Vijver, K., Lambrechts, D., & Vergote, I. (March 2023). Value of testing for homologous recombination repair deficiency in newly diagnosed advanced-stage epithelial ovarian cancer: Recommendations for Belgian physicians. Belgian Journal of Medical Oncology, 17 (2), 38-45.

Lumaka Zola, A., Fasquelle, C., Debray, F.-G., Alkan, S., Jacquinet, A., Harvengt, J., Boemer, F., Mulder, A., VAESSEN, S., Viellevoye, R., Gonon Rodrigues Palmeira, L., CHARLOTEAUX, B., Brysse, A., BULK, S., Rigo, V., & Bours, V. (16 February 2023). Rapid Whole Genome Sequencing Diagnoses and Guides Treatment in Critically Ill Children in Belgium in Less than 40 Hours. International Journal of Molecular Sciences, 24 (4), 4003. doi:10.3390/ijms24044003

DHEUR, A., Salmon, A., Streel, S., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (February 2023). p53 status : a strong negative prognostic factor in endometrial carcinoma [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium.

Salmon, A., Streel, S., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2023). Agreement between immunohistochemistry and molecular techniques to assess microsatellite instability and p53 status in endometrial cancer [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium.

NECHIFOR - POTORAC, I., Laterre, M., Malaise, O., NECHIFOR, V. A., Fasquelle, C., Colleye, O., Detrembleur, N., Verdin, H., Symoens, S., De Baere, E., Daly, A., Bours, V., Pétrossians, P., & Pintiaux, A. (28 January 2023). The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency. Journal of Clinical Medicine, 12 (3). doi:10.3390/jcm12030990

Meuris, C., Darcis, G., Orban, C., Hayette, M.-P., Meex, C., Desmecht, D., & Bours, V. (2023). Study of asymptomatic rectal carriage of Monkeypox virus in men who have sex with men, and immunological answer to vaccination, followed in Liège University Hospital.

Jacquinet, A., Flasse, L., Dohet, M., Pendeville-Samain, H., Plougonven, E., Léonard, A., Guerrier, D., Peers, B., & Bours, V. (2023). Identification of NR6A1 as a new gene involved in congenital urogenital anomalies [Poster presentation]. 56th European Human Genetics Conference 2023.

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., Atoba Bokele, C., BOURS, V., Azerad, M.-A., Tonen-Wolyec, S., Kayembe Tshilumba, C., & Batina-Agasa, S. (December 2022). Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study. Hematology (Amsterdam, Netherlands), 27 (1), 590-595. doi:10.1080/16078454.2022.2074715

Garcia-Pelaez, J., Barbosa-Matos, R., Lobo, S., Dias, A., Garrido, L., Castedo, S., Sousa, S., Pinheiro, H., Sousa, L., Monteiro, R., Maqueda, J. J., Fernandes, S., Carneiro, F., Pinto, N., Lemos, C., Pinto, C., Teixeira, M. R., Aretz, S., Bajalica-Lagercrantz, S., ... Oliveira, C. (24 November 2022). Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. The Lancet Oncology, 24 (1), 91-106. doi:10.1016/S1470-2045(22)00643-X

KAMBALE KOMBI, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., Sepulchre, E., Bours, V., Floc'h, A., Pirenne, F., Kayembe Tshilumba, C., & Batina-Agasa, S. (2022). Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo. Transfusion Medicine. doi:10.1111/tme.12939

Cuypers, L., Dellicour, S., Hong, S. L., Potter, B. I., Verhasselt, B., Vereecke, N., Lambrechts, L., Durkin, K., Bours, V., Klamer, S., Bayon-Vicente, G., Vael, C., Ariën, K. K., De Mendonca, R., Soetens, O., Michel, C., Bearzatto, B., Naesens, R., Gras, J., ... Baele, G. (20 October 2022). Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants. Viruses, 14 (10), 2301. doi:10.3390/v14102301

Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203

Dubois, N., Berendsen, S., Tan, K., Schoysmans, L., Spliet, W., Seute, T., Bours, V., & Robe, P. (October 2022). STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas. International Journal of Oncology, 61 (4). doi:10.3892/ijo.2022.5414

Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264

DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States.

Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States.

Kasai, E. T., Kadima, J. N., Alworong'a Opara, J. P., Boemer, F., Dresse, M. F., Makani, J., Bours, V., Marini Djang'Eing'A, R., Paul, K.-K., & Batina Agasa, S. (08 August 2022). Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree:  a case study in Kisangani, the Democratic Republic of the Congo. Hematology (Amsterdam, Netherlands), 27 (1), 853-859. doi:10.1080/16078454.2022.2107351

Kambale-Kombi, P., Marini Djang'Eing'A, R., ALWORONG’A OPARA, J., MINON, J., Sepulchre, E., Bours, V., FLOCH, A., PIRENNE, F., KAYEMBE TSHILUMBA, C., & BATINA AGASA, S. (August 2022). P-035: RED BLOOD CELL ALLOIMMUNIZATION IN SICKLE CELL DISEASE PATIENTS IN THE DEMOCRATIC REPUBLIC OF THE CONGO. HemaSphere, 6, 34-34. doi:10.1097/01.hs9.0000873036.01916.17

Kambale-Kombi, P., Djang'eing'a, R. M., Alworong'a Opara, J.-P., Mbo Mukonkole, J.-P., Bours, V., Tonen-Wolyec, S., Mbumba Lupaka, D.-M., Bome, L. B., Tshilumba, C. K., & Batina-Agasa, S. (14 July 2022). Renal Abnormalities among Sickle Cell Disease Patients in a Poor Management Setting: A Survey in the Democratic Republic of the Congo. Mediterranean Journal of Hematology and Infectious Diseases, 14 (1), 2022046. doi:10.4084/MJHID.2022.046

Kukor, L., BERTOLI, S., CREVECOEUR, J., Bours, V., & BULK, S. (21 April 2022). What does a Genetic Counsellor do in the University Hospital of Liège ? [Poster presentation]. BeSHG/NVHG Annual Genetics Symposium 2022.

KEMPENEERS, C., Bricmont, N., Bonhiver, R., GUISSARD, F., HOUGRAND, O., DELVENNE, P., JACQUINET, A., HARVENGT, J., DOCAMPO MARTINEZ, E., BOURS, V., Benchimol, L., POIRRIER, A.-L., LEFEBVRE, P., CALMES, D., LOUIS, R., & SEGHAYE, M.-C. (17 March 2022). Ciliary videomicroscopy at room temperature lacks sensitivity for PCD diagnosis [Poster presentation]. Congress of the BVK-SBP, Brussels, Belgium.

HARVENGT, J., Lumaka Zola, A., FASQUELLE, C., & BOURS, V. (26 February 2022). HIDEA Syndrome : A new case report highlighting similarities with ROHHAD Syndrome [Poster presentation]. ROHHAD International Consortium Virtual Symposium.

BOEMER, F., JOSSE, C., LUIS, G., Di Valentin, E., Thiry, J., CELLO, C., CABERG, J.-H., DADOUMONT, C., HARVENGT, J., Lumaka, A., BOURS, V., & DEBRAY, F.-G. (18 February 2022). Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences, 23 (4), 2253. doi:10.3390/ijms23042253

Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721
* These authors have contributed equally to this work.

Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581

Gennigens, C., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., Seidel, L., Streel, S., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Salmon, A. (2022). 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular analysis ? International Journal of Gynecological Cancer. doi:10.1136/ijgc-2022-ESGO.266

I. Vergote, H. Denys, S. Altintas, J. Kerger, J-F. Baurain, Bours, V., S. Henry, K. Van de Vijver, D. Lambrechts, & Gennigens, C. (2022). Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer:A Belgian expert opinion. Facts, Views and Vision in Obgyn, 14 (2), 111-120.

Thissen, R., ARTESI, M., Durkin, K., JOSSE, C., PALMEIRA, L., & BOURS, V. (24 December 2021). Comprehensive detection of homologous recombination deficiency by Nanopore sequencing [Poster presentation]. GIGA cancer day, Liège, Belgium.

Gordon, D. M., Beckers, P., CASTERMANS, E., Neggers, S. J., ROSTOMYAN, L., Bours, V., Pétrossians, P., Dideberg, V., Beckers, A., & Daly, A. (01 December 2021). Dutch Founder SDHB Exon 3 Deletion in Patients with Pheochromocytoma-Paraganglioma in South Africa. Endocrine Connections, 11 (1). doi:10.1530/EC-21-0560

VALDES SOCIN, H. G., ANDRIS, C., CROMMEN, J., PETROSSIANS, P., BOURS, V., & DEBRAY, F.-G. (December 2021). It’s all in their eyes: a three-generation family with branchio-oculo-facial syndrome (BOFS) reveals a heterozygous novel mutation in TFAP2A gene. Acta Clinica Belgica, 2 (76), 27-29.

Sonet, I., Gonon Rodrigues Palmeira, L., CHARLOTEAUX, B., CABERG, J.-H., Dideberg, V., & Bours, V. (17 September 2021). Validation of a CNV detection method on clinical-grade Exomes [Poster presentation]. 21th BeSHG meeting, Bruxelles, Belgium.

VALDES SOCIN, H. G., LIBIOULLE, C., PETIGNOT, S., BETEA, D., PINTIAUX, A., DIVE, D., DEBRAY, F.-G., BOURS, V., & PETROSSIANS, P. (17 September 2021). Male and female hypogonadotropic hypogonadism associated with two novel non sense heterozygous mutations of Klotho beta gene (KLB) [Poster presentation]. Belgian Society of Genetics, Bruxelles, Belgium.

Poncin, A., Onesti, C. E., JOSSE, C., Boulet, D., Thiry, J., Bours, V., & Jerusalem, G. (August 2021). Immunity and Breast Cancer: Focus on Eosinophils. Biomedicines, 9 (9), 1087. doi:10.3390/biomedicines9091087

LETE, C., Ameye, G., BECKERS, P., Michaux, L., BOURS, V., JAMAR, M., De Bie, J., Dewaele, B., & MENTEN, C. (July 2021). CASE REPORT: the use of optical genome mapping (Bionano) to understand a complex mechanism of a KMT2A rearrangement in an AML case [Poster presentation]. 13th European Cytogenomics Conference.

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

Van Campenhout, C., De Mendonça, R., Alexiou, B., De Clercq, S., Racu, M.-L., Royer-Chardon, C., Rusu, S., Van Eycken, M., ARTESI, M., Durkin, K., Mardulyn, P., BOURS, V., Decaestecker, C., Remmelink, M., Salmon, I., & D'Haene, N. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues. The Journal of Molecular Diagnostics. doi:10.1016/j.jmoldx.2021.05.016

Uyisenga, J. P.* , Debit, A.* , Poulet, C., Frères, P., Poncin, A., Thiry, J., Mutesa, L., Jerusalem, G., Bours, V.* , & JOSSE, C.*. (03 June 2021). Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites. Scientific Reports, 11 (1), 11698. doi:10.1038/s41598-021-91278-0
* These authors have contributed equally to this work.

BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (04 February 2021). Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon‑skipping therapy. Scientific Reports, 11, 3011. doi:10.1038/s41598-021-82725-z

Artesi, M.* , Hahaut, V.* , Cole, B.* , Lambrechts, L., Ashrafi, F., Marçais, A., Hermine, O., Griebel, P., Arsic, N., van der Meer, F., Burny, A., Bron, D., BIANCHI, E., DELVENNE, P., BOURS, V., Charlier, C., Georges, M., Vandekerckhove, L.* , Van den Broeke, A.* , & Durkin, K.*. (2021). PCIP-seq: simultaneous sequencing of integrated viral genomes and their integration sites with long reads. Genome Biology, 22, 97. doi:10.1186/s13059-021-02307-0
* These authors have contributed equally to this work.

BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (2021). Newborn Screening of Duchenne Muscular Dystrophy Specifically Targeting Deletions Amenable to Exon-skipping Therapy [Poster presentation]. European Human Genetics Conference - ESHG.

BOEMER, F., Caberg, J.-H., Beckers, P., Dideberg, V., di Fiore, S., Bours, V., Marie, S., Dewulf, J., Marcelis, L., Deconinck, N., Daron, A., Blasco-Perez, L., Tizzano, E., Hiligsmann, M., Lombet, J., Pereira, T., Lopez-Granados, L., Shalchian-Tehran, S., van Assche, V., ... Servais, L. (2021). Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Scientific Reports, 11 (1), 19922. doi:10.1038/s41598-021-99496-2

Bollen, N., Artesi, M., Durkin, K., Hong, S. L., Potter, B., Boujemla, B., Vanmechelen, B., Martí-Carreras, J., Wawina-Bokalanga, T., Meex, C., Bontems, S., Hayette, M.-P., André, E., Maes, P., Bours, V., Baele, G., & Dellicour, S. (2021). Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020. Scientific Reports, 11 (1), 18580. doi:10.1038/s41598-021-97667-9

Butera, Y., Mukantwari, E., Artesi, M., Umuringa, J. D. A., O'Toole, Á. N., Hill, V., Rooke, S., Hong, S. L., Dellicour, S., Majyambere, O., Bontems, S., Boujemla, B., Quick, J., Resende, P. C., Loman, N., Umumararungu, E., Kabanda, A., Murindahabi, M. M., Tuyisenge, P., ... Rujeni, N. (2021). Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity. Nature Communications, 12 (1), 5705. doi:10.1038/s41467-021-25985-7

Dellicour, S., Durkin, K., Hong, S., Vanmechelen, B., Marti-Carreras, J., Gill, M., Meex, C., Bontems, S., André, E., Gilbert, M., Walker, C., De Maio, N., Hadfield, J., Hayette, M.-P., Bours, V., Wawina-Bokalanga, T., Artesi, M., Baele, G., Maes, P., & Faria, N. R. (2021). A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages. Molecular Biology and Evolution. doi:10.1093/molbev/msaa284

DOCAMPO MARTINEZ, E., MARTIN, M., GANGOLF, M., HARVENGT, J., BULK, S., SEGERS, K., LEROI, N., LETE, C., PALMARICCIOTTI, V., Freire Chadrina, M., LAMBERT, F., & Bours, V. (2021). Hérédité et cancer. Revue Médicale de Liège, 76 (5-6), 327-336.

Hoogstrate, Y., Ghisai, S. A., de Wit, M., de Heer, I., Draaisma, K., van Riet, J., van de Werken, H. J. G., Bours, V., Buter, J., Vanden Bempt, I., Eoli, M., Franceschi, E., Frenel, J.-S., Gorlia, T., Hanse, M. C., Hoeben, A., Kerkhof, M., Kros, J. M., Leenstra, S., ... French, P. J. (2021). The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis. Neuro-Oncology. doi:10.1093/neuonc/noab231

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., BOEMER, F., BOURS, V., Tonen-Wolyec, S., Kayembe Tshilumba, C., & Batina-Agasa, S. (January 2021). Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematology, 26 (1), 199-205. doi:10.1080/16078454.2021.1880752

Maclot, F., Bontems, S., Meex, C., Artesi, M., Beckers, P., Bours, V., Durkin, K., & Hayette, M.-P. (2021). Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant. The Journal of infection, 83 (1), 19-e21. doi:10.1016/j.jinf.2021.04.035

Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757

Van Den Bogaert, K., Lannoo, L., Brison, N., Gatinois, V., Baetens, M., Blaumeiser, B., BOEMER, F., Bourlard, L., Bours, V., De Leener, A., De Rademaeker, M., Désir, J., Dheedene, A., Duquenne, A., Fieremans, N., Fieuw, A., GATOT, J.-S., Grisart, B., Janssens, K., ... Vermeesch, J. R. (2021). Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genetics in medicine : official journal of the American College of Medical Genetics, 23 (6), 1137-1142. doi:10.1038/s41436-021-01101-4

Wislet-Gendebien, S., Poulet, C., Neirinckx, V., Hennuy, B., Swingland, J. T., Laudet, E., Sommer, L., Shakova, O., Bours, V., & Rogister, B. (2021). Correction: In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 16 (9), 0256477. doi:10.1371/journal.pone.0256477

Onesti, C. E., JOSSE, C., Boulet, D., Bours, V., & JERUSALEM, G. (2020). High plasmatic levels of IL-4 and IL- 13 are associated with recurrence and worse survival in breast cancer. Tumori Journal.

ONESTI, C. E., JOSSE, C., Beaumecker, B., Boulet, D., Thiry, J., BOURS, V., & JERUSALEM, G. (2020). The relative eosinophil count in breast cancer as an emerging prognostic biomarker. European Journal of Cancer. doi:10.1016/S0959-8049(20)30766-8

Artesi, M., Bontems, S., Göbbels, P., Franckh, M., Maes, P., BOREUX, R., MEEX, C., MELIN, P., Hayette, M.-P., Bours, V., & Durkin, K. (2020). A recurrent mutation at position 1 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay. Journal of Clinical Microbiology. doi:10.1128/JCM.01598-20

PETIGNOT, S., Daly, A., CASTERMANS, E., Korpershoek, E., Scagnol, I., BECKERS, P., Dideberg, V., Rohmer, V., Bours, V., & Beckers, A. (2020). Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Hormone and Metabolic Research. doi:10.1055/a-1186-0790

HARVENGT, J., ALKAN, S., Florkin, B., BULK, S., & Bours, V. (June 2020). POP1-Skeletal dysplasias : description of two new families [Poster presentation]. European Human Genetics Virtual Conference 2020.

DOCAMPO MARTINEZ, E., MARTIN, M., Marnette, J., & Bours, V. (06 March 2020). LTBP3 mutation identified in a patient with a severe valvular disease [Poster presentation]. 20th Annual Meeting of the Belgian Society of Human Genetics.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

Debray, F.-G., WEEKERS, L., Dadoumont, C., Grandjean, C., DEBERG, M., Boemer, F., & Bours, V. (2020). Actualités thérapeutiques dans les erreurs innées du métabolisme. Revue Médicale de Liège, 75 (5-6), 420-425.

Frebourg, T., Bajalica Lagercrantz, S., Oliveira, C., Magenheim, R., Evans, D. G., Hoogerbrugge, N., Ligtenberg, M., Kets, M., Oostenbrink, R., Sijmons, R., Evans, G., Woodward, E., Tischkowitz, M., Maher, E., Ferner, R. E., Aretz, S., Spier, I., Steinke-Lange, V., Holinski-Feder, E., ... The European Reference Network GENTURIS. (2020). Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes. European Journal of Human Genetics. doi:10.1038/s41431-020-0638-4

Frebourg, T., Lagercrantz, S. B., Oliveira, C., Magenheim, R., Evans, D. G., Hoogerbrugge, N., Ligtenberg, M., Oostenbrink, R., Sijmons, R., Woodward, E., Tischkowitz, M., Maher, E., Ferner, R. E., Aretz, S., Spier, I., Steinke-Lange, V., Holinski-Feder, E., Schröck, E., Frebourg, T., ... the European Reference Network GENTURIS. (2020). Reply to Kratz et al [letter to the editor]. European Journal of Human Genetics. doi:10.1038/s41431-020-00710-y

HARVENGT, J., GERNAY, C., Mastouri, M., FARHAT, N., LEBRETHON, M.-C., Seghaye, M.-C., & Bours, V. (2020). ROHHAD(NET) Syndrome: Systematic review of the clinical timeline and recommendations for diagnosis and prognosis. Journal of Clinical Endocrinology and Metabolism. doi:10.1210/clinem/dgaa247

Jacquinet, A., Boujemla, B., FASQUELLE, C., Thiry, J., JOSSE, C., Lumaka, A., Brischoux-Boucher, E., Dubourg, C., David, V., Pasquier, L., Lehman, A., Morcel, K., Guerrier, D., & Bours, V. (2020). GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer-Rokitansky-Kuster-Hauser syndrome. Clinical Genetics, 98 (2), 126-137. doi:10.1111/cge.13769

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Wa Inena, G. I., Falay Sadiki, D., BOEMER, F., BOURS, V., Tshilumba, C. K., & Batina-Agasa, S. (2020). Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo. Pan African Medical Journal, 35, 127. doi:10.11604/pamj.2020.35.127.21113

Leclercq, P., Jadot, V., Bours, V., Oliveira, C., Neumann, H., & Bisschops, R. (2020). Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch? [letter to the editor]. Therapeutic Advances in Gastroenterology, 13. doi:10.1177/1756284820916399

Mubungu, G., Makay, P., Boujemla, B., Yanda, S., Posey, J. E., Lupski, J. R., Bours, V., Lukusa, P., Devriendt, K., & Lumaka, A. (2020). Clinical presentation and evolution of Xia-Gibbs syndrome due to p.Gly375ArgfsTer3 variant in a patient from DR Congo (Central Africa). American Journal of Medical Genetics. Part A. doi:10.1002/ajmg.a.62049

ONESTI, C. E., JOSSE, C., Boulet, D., Thiry, J., Beaumecker, B., BOURS, V., & JERUSALEM, G. (2020). Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse. Oncoimmunology. doi:10.1080/2162402X.2020.1761176

Tischkowitz, M., Colas, C., Pouwels, S., Hoogerbrugge, N., Bisseling, T., Bubien, V., Caux, F., Chabbert-Buffet, N., Colas, C., Da Mota Gomes, S., Gotthardt, M., Hoogerbrugge, N., Kets, M., Lachlan, K. L., Links, T. P., Longy, M., Mann, R., Pouwels, S., Kool, L. S., ... The European Reference Network GENTURIS. (2020). Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. European Journal of Human Genetics. doi:10.1038/s41431-020-0651-7

Uyisenga, J., Butera, Y., Debit, A., JOSSE, C., Ainhoa, C. C., Karinganire, E., Cyuzuzo, A. P., Umurungi, N., Kalinijabo, Y., Uwimana, S., Mutesa, L., & Bours, V. (2020). Prevalence of Histological Characteristics of Breast Cancer in Rwanda in Relation to Age and Tumor Stages. Hormones and Cancer. doi:10.1007/s12672-020-00393-3

Uyisenga, J., SEGERS, K., Lumaka, A. Z., Mugenzi, P., FASQUELLE, C., Boujemla, B., JOSSE, C., Mutesa, L., & Bours, V. (2020). Screening of germline mutations in young Rwandan patients with breast cancers. Molecular Genetics and Genomic Medicine. doi:10.1002/mgg3.1500

Uyisenga, J., SEGERS, K., Butera, Y., Musoni, E., Uwimana, S., Habanabakize, T., Ruzigana, G., Mugenzi, P., JOSSE, C., BOURS, V., & Mutesa, L. (04 December 2019). Primary sarcoma of the breast in the young Rwandan females. Breast Cancer Reports, 6 (2). doi:10.7243/2057-1631-6-2

Uyisenga, J., SEGERS, K., Lumaka Zola, A., Mugenzi, P., Boujemla, B., JOSSE, C., Mutesa, L., & BOURS, V. (26 September 2019). Germline mutations in young Rwandan with breast cancers [Paper presentation]. The Joint Minimally Invasive Surgery (MIS) & 3rd Rwanda Biotechnology Conference, Kigali, Rwanda.

BOEMER, F., CABERG, J.-H., DIDEBERG, V., BECKERS, P., Marie, S., Marcelis, L., Bours, V., Dangouloff, T., & Servais, L. (September 2019). (S)un (M)ay (A)rise on SMA : l'espoir d'une region sans amyotrophie spinale. Revue Médicale de Liège, 74 (9), 461-464.

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., Poulet, C., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome. Annals of Oncology.

VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2019). A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants. In Endocrine Abstracts - ECE 2019.

Debit, A., Poulet, C., JOSSE, C., Azencott, C.-A., Jerusalem, G., Van Steen, K., & BOURS, V. (15 March 2019). TOWARDS AN ACCURATE CANCER DIAGNOSIS MODELIZATION:COMPARISON OF RANDOM FOREST STRATEGIES [Poster presentation]. 19th BeSHG meeting 15th March 2019 Liege, Belgium, Liege, Belgium.

HARVENGT, J., Boros, E., BULK, S., & Bours, V. (15 March 2019). COL1A2 mutation in a case of isolated short stature [Poster presentation]. 19th Annual Meeting of the Belgian Society of Human Genetics, Liège, Belgium.

Latge, G., Poulet, C., JOSSE, C., JERUSALEM, G., & Bours, V. (15 March 2019). Role of DNA methylation in INK4a-ARF-INK4b locus expression in breast cancer [Poster presentation]. 19th Meeting of the Belgian Society of Human Genetics, Liège, Belgium.

Daly, A., Cano, D. A., Venegas, E., PETROSSIANS, P., Dios, E., CASTERMANS, E., Flores-Martinez, A., Bours, V., Beckers, A., & Soto, A. (2019). AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocrine Connections. doi:10.1530/EC-19-0027

Berendsen, S., Spliet, W. G. M., Geurts, M., Van Hecke, W., Seute, T., Snijders, T. J., Bours, V., Bell, E. H., Chakravarti, A., & Robe, P. (2019). Epilepsy associates with decreased HIF-1α/STAT5b signaling in glioblastoma. Cancers, 11 (1). doi:10.3390/cancers11010041

Berendsen, S., van Bodegraven, E., Seute, T., Spliet, W. G. M., Geurts, M., Hendrikse, J., SCHOYSMAN, L., Huiszoon, W. B., Varkila, M., Rouss, S., Bell, E. H., Kroonen, J., Chakravarti, A., Bours, V., Snijders, T. J., & Robe, P. (2019). Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates. PLoS ONE, 14 (10), 0222717. doi:10.1371/journal.pone.0222717

Boemer, F., CABERG, J.-H., Dideberg, V., DARDENNE, D., Bours, V., Hiligsmann, M., Dangouloff, T., & Servais, L. (2019). Newborn screening for SMA in Southern Belgium. Neuromuscular Disorders. doi:10.1016/j.nmd.2019.02.003

Draaisma, K., Chatzipli, A., Taphoorn, M., Kerkhof, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukacova, S., Lombardi, G., Leenstra, S., Hanse, M., Fleischeuer, R., Watts, C., McAbee, J., Angelopoulos, N., Gorlia, T., Golfinopoulos, V., Kros, J. M., Verhaak, R. G. W., ... French, P. J. (2019). Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1900367. doi:10.1200/JCO.19.00367

JADOT, V., SEGERS, K., Bours, V., KOHNEN, L., HONORE, P., MARTIN, M., DE FLINES, J., MUTIJIMA NZARAMBA, E., & LECLERCQ, P. (2019). Cancer gastrique diffus héréditaire Série de 8 patients appartenant à une même famille et revue de la littérature. Revue Médicale de Liège, 74 (3), 134-138.

Lion, L., LECLERCQ, P., Plomteux, O., & Bours, V. (2019). Etude des risques oncologiques associés au syndrome de Lynch en région liégeoise. Revue Médicale de Liège, 74 (9), 479-483.

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. Journal of Translational Medicine, 17, 239. doi:10.1186/s12967-019-1984-2

Uwineza, A., CABERG, J.-H., Hitayezu, J., Wenric, S., Mutesa, L., Vial, Y., Drunat, S., Passemard, S., Verloes, A., El Ghouzzi, V., & Bours, V. (2019). VPS51 biallelic variants cause microcephaly with brain malformations: A confirmatory report. European Journal of Medical Genetics, 62 (8). doi:10.1016/j.ejmg.2019.103704

VALDES SOCIN, H. G., Rey, R., COPPENS, L., JAMAR, M., Bours, V., & Beckers, A. (2019). Le syndrome de Klinefelter : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 24 (1).

Gulbis, B., Lê, P.-Q., Ketelslegers, DRESSE, M.-F., Adam, A.-S., Cotton, F., BOEMER, F., BOURS, V., Minon, J.-M., & Ferster, A. (2018). Neonatal Screening for Sickle Cell Disease in Belgium for More than 20 Years: An Experience for Comprehensive Care Improvement. International Journal of Neonatal Screening. doi:10.3390/ijns4040037

Debit, A., Poulet, C., JOSSE, C., Van Steen, K., JERUSALEM, G., Bours, V., & Azencott, C.-A. (05 October 2018). Towards an accurate cancer diagnosis modelization: Comparison of Random Forest strategies [Poster presentation]. 5th conference Bioinformatics for young international researchers expo byteMAL 2018, Liege, Belgium.

Uyisenga, J., SEGERS, K., Lumaka Zola, A., Mugenzi, P., FASQUELLE, C., Boujemla, B., JOSSE, C., Mutesa, L., & Bours, V. (20 September 2018). Screening of germline mutations in young Rwandan with breast cancer [Paper presentation]. Joint 11th Conference of African Society of Human Genetics (AfSHG)& 12th H3 Africa Consortium Meeting, Kigali, Rwanda.

ONESTI, C. E., JOSSE, C., Poncin, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (2018). Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment. Oncotarget. doi:10.18632/oncotarget.26120

Debit, A., JOSSE, C., JERUSALEM, G., BOURS, V., & Poulet, C. (13 September 2018). Towards an accurate cancer diagnosis modelization:Comparison of Random Forest strategies [Poster presentation]. JOINT MEETING GIGA-CANCER DAY 2018 / EDT-CANCEROLOGY, Liege, Belgium.

Latgé, G., JOSSE, C., Poulet, C., Bours, V., & Jerusalem, G. (13 September 2018). Role of DNA methylation in INK4a-ARF-INK4b locus expression in breast cancer [Poster presentation]. GIGA-Cancer DAY, Liege, Belgium.

ONESTI, C. E., JOSSE, C., PONCIN, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (13 September 2018). Predictive and prognostic role of peripheral blood eosinophil count in triple negative and hormone receptor negative/HER2 positive breast cancers patients undergoing neoadjuvant treatment [Paper presentation]. GIGA-Cancer Day 2018 / EDT-Cancerology Vascular landscape and (pre)metastatic niche in cancer biology.

Uyisenga, J., SEGERS, K., Lumaka Zola, A., Mugenzi, P., FASQUELLE, C., Boujemla, B., JOSSE, C., Mutesa, L., & Bours, V. (11 September 2018). Germline mutations in young Rwandan with breast cancers [Poster presentation]. GIGA Cancer Day, Liège, Belgium.

Parotte, M.-C., CASTERMANS, E., Bours, V., Beckers, A., & VALDES SOCIN, H. G. (September 2018). Hypercalcémie familiale bénigne révélée par des crises de colique néphrétique : description d'une nouvelle mutation du calcium sensing receptor (CasR) [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., Debray, F.-G., HARVENGT, J., LIBIOULLE, C., DIDEBERG, V., Bours, V., & Beckers, A. (September 2018). CHD7 impliqué dans l'hypogonadisme hypogonadotrope avec ou sans anosmie : description de 3 patients et de 3 nouvelles mutations [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., Geenen, V., CORMAN, V., DEBRAY, F.-G., Dideberg, V., T'sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Burlacu, C., VROONEN, L., Bours, V., ... Beckers, A. (September 2018). Etude multicentrique belge chez 56 patients avec hypogonadisme hypogonadotrope congénital (HHC) : caractérisation des anomalies génétiques et cérébrales [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., LIBIOULLE, C., Tsjoen, G., DEBRAY, F.-G., Bours, V., & Beckers, A. (September 2018). TAC3 et TACR3 impliqués dans l'hypogonadisme hypogonadotrope normosmique : description de trois patients avec des nouvelles mutations [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., PINTIAUX, A., JONAS, C., Parent, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Bours, V., Maiter, D., & Beckers, A. (May 2018). The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH) : genetics and brain abnormalities [Poster presentation]. 20th European Congress of Endocrinology.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., BOURS, V., Maiter, D., & BECKERS, A. (2018). Brain imaging and genetics in patients with congenital hypogonadotropic hypogonadism: a multicenter Belgian study. In J. O. Jorgensen, NENEG Abstract Book Communications (pp. 64). Aarhus, Denmark: Pfizer.

Daly, A.* , CASTERMANS, E.* , Oudijk, L., Guitelman, M. A., BECKERS, P., NECHIFOR, I., Neggers, S. J. C. M. M., SACRE, N., Van der Lely, A. J., Bours, V., de Herder, W. W., & Beckers, A. (13 March 2018). Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocrine-Related Cancer, 25 (5), 37–42. doi:10.1530/ERC-18-0065
* These authors have contributed equally to this work.

DUBOIS, N., Berendsen, S., HENRY, A., Nguyen, M., Bours, V., & Robe, P. A. (26 February 2018). I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors. Cancer Translational Medicine, 4 (1), 1-8. doi:10.4103/ctm.ctm_3_18

BERTOLI, S., VAN CASTEREN, L., Bours, V., & BULK, S. (16 February 2018). The cardiogenetics consultation : an inventorisation of the Liege population [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

HARVENGT, J., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & VALDES SOCIN, H. G. (16 February 2018). Brain MRI abnormalities and genetic results in a series of 30 patients with congenital isolated hypogonadotrophic hypogonadism (CIHH) [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

KUKOR, L., BERTOLI, S., Bours, V., BULK, S., & DOCAMPO MARTINEZ, E. (16 February 2018). Ehlers-Danlos syndrome in the University Hospital of Liege [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366

Freres, P., Bouznad, N., Servais, L., JOSSE, C., Wenric, S., Poncin, A., Thiry, J., Moonen, M., Oury, C., Lancellotti, P., Bours, V., & Jerusalem, G. (2018). Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients. BMC Cancer, 18 (1). doi:10.1186/s12885-018-4015-4

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2

Latge, G., Poulet, C., Bours, V., JOSSE, C., & Jerusalem, G. (2018). Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers. International Journal of Molecular Sciences, 19 (1). doi:10.3390/ijms19010123

Lenglet, M., Robriquet, F., Schwarz, K., Camps, C., Couturier, A., Hoogewijs, D., Buffet, A., Knight, S. J. L., Gad, S., Couvé, S., Chesnel, F., Pacault, M., Lindenbaum, P., Job, S., Dumont, S., Besnard, T., Cornec, M., Dreau, H., Pentony, M., ... Gardie, B. (2018). Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease. Blood, 132 (5), 469-483. doi:10.1182/blood-2018-03-838235

RAMAEKERS, V., SEGERS, K., Sequeira, J. M., Koenig, M., Van Maldergem, L., Bours, V., Kornak, U., & Quadros, E. V. (2018). Genetic assessment and folate receptor autoantibodies in infantile-onset cerebral folate deficiency (CFD) syndrome. Molecular Genetics and Metabolism, 124 (1), 87-93. doi:10.1016/j.ymgme.2018.03.001

VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2018). Le Syndrome de Kallmann: un vieux syndrome revisité par la génétique. Urologic, 14, 1-7.

Vos, J. R., Giepmans, L., Rohl, C., Geverink, N., Hoogerbrugge, N., & Bours, V. (Other coll.). (2018). Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes. Familial Cancer. doi:10.1007/s10689-018-0110-6

Marini Djang'Eing'A, R., Batina Agasa, S., Gulbis, B., BOURS, V., Razy, E., Frederich, M., Guillaume, M., Etienne, A.-M., Mbinze Kindenge, J., Kimoni Kicha, ALWORONG’A OPARA ATIM-NEDI, J.-P., BORIVE AMANI, M., KASONGO MALOBA, P., OPESA LOHATA, A., BANSANDJA LONGEMBE, E., MAVINGA TANA, A., & Hubert, P. (06 October 2017). Drepakis : Contribution to the management of Sickle cell disease in the city of Kisangani (D.R. Congo) [Paper presentation]. 5th Annual International Scientific Conference Society for the Advancement of Science in Africa (SASA) and 2nd Rwanda Biotechnology Conference, Kigali, Rwanda.

VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., DIDEBERG, V., BOURS, V., & Beckers, A. (2017). Syndrome de charge atypique avec hypogonadisme hypogonadotrope anosmique : description de 2 nouvelles mutations. In Annales d'Endocrinologie - abstract book.

HARVENGT, J., SAGOT, C., Decortis, T., Damry, N., Rondia, CABERG, J.-H., Bours, V., & BULK, S. (27 May 2017). A tale of two anomalies. A paternal duplication and a maternal deletion of 15q13 [Poster presentation]. European Human Genetics Conference, Copenhague, Denmark.

Debit, A., Wenric, S., JOSSE, C., Van Steen, K., & Bours, V. (May 2017). Normalization and correction for batch effects via RUV for RNA-seq data: practical implications for Breast Cancer Research [Poster presentation]. European Human Genetics Conference ESHG 2017, Copenhagen, Denmark.

Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark.

BOEMER, F., Fasquelle, C., D'OTREPPE DE BOUVETTE, S., JOSSE, C., DIDEBERG, V., SEGERS, K., GUISSARD, V., CAPRARO, V., Debray, F.-G., & Bours, V. (2017). A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases. Scientific Reports, 7 (1), 17641. doi:10.1038/s41598-017-18038-x

Courtois, A., Coppieters, W., BOURS, V., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2017). A novel SMAD3 mutation caused multiple aneurysms in a patient without osteoarthritis symptoms. European Journal of Medical Genetics. doi:10.1016/j.ejmg.2017.02.001

Detemmerman, L., Olivier, S., BOURS, V., & BOEMER, F. (2017). Innovative PCR without DNA extraction for African sickle cell disease diagnosis. Hematology, 1-6. doi:10.1080/10245332.2017.1371470

Goffart, N.* , LOMBARD, A.* , Lallemand, F., Kroonen, J., Nassen, J., Di Valentin, E., Berendsen, S., Dedobbeleer, M., Willems, E., Robe, P., Bours, V., Martin, D., Martinive, P., Maquet, P., & Rogister, B. (2017). CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro-Oncology, 19 (1), 66-77. doi:10.1093/neuonc/now136
* These authors have contributed equally to this work.

Oury, C., & Bours, V. (2017). Pharmacogenomics screening. In M. Galderisi, P. Lancellotti, ... J. Zamorano Gomez (Eds.), Anticancer treatments and cardiotoxicity. Elsevier. doi:10.1016/B978-0-12-802509-3.00038-8

Potorac, I., CORMAN, V., Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & Beckers, A. (2017). Genetic predisposition to breast cancer occuring in a male-to-female transsexual patient. In Abstract book : Symposium "Perspectives in Endocrinology".

Rostomyan, L., Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., de Herder, W., Naves, L., Metzger, D., Cuny, T., Rabl, W., Shah, N., Jaffrain-Rea, M., Zatelli, M., Faucz, F., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... Beckers, A. (2017). Somatic mosaicism is implicated in the etiology of XLAG syndrome. In Abstract book : Symposium "Perspectives in Endocrinology".

Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397

Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2

Wenric, S.* , Sticca, T.* , CABERG, J.-H., Josse, C., Fasquelle, C., HERENS, C., JAMAR, M., MAX, S., GOTHOT, A., CAERS, J., & Bours, V. (2017). Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample. Genetic Epidemiology, 41, 35-40. doi:10.1002/gepi.22019
* These authors have contributed equally to this work.

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (29 November 2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. 28th EORTC-NCI-AACR symposium on "Molecular targets and cancer therapeutics", Munich, Germany.

Rostomyan, L., Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., de Herder, W., Naves, L. A., Metzger, D., Cuny, T., Rabl, W., Shah, N., Jaffrain-Rea, M., Zatelli, M., Faucz, F., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... Beckers, A. (2016). Somatic mosaicism is implicated in the etiology of XLAG syndrome. In 26nd meeting of the Belgian Endocrine Society - Abstract book.

VALDES SOCIN, H. G., CORMAN, V., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Hypogonadisme hypogonadotrope anosmique associé à une nouvelle mutation hétérozygote c.937C>T, p.His314Tyr de l'isoforme IIIb du gène FGR1. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie.

VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., VROONEN, L., DIDEBERG, V., Bours, V., & BECKERS, A. (2016). Caractérisation clinique, neuroendocrinienne, génétique et résultats thérapeutiques dans le syndrome de Kallmann et de l'hypogonadisme normosmique idiopathique : expérience liégeoise. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie.

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (09 September 2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. Annual Mini Symposium - EDT-Cancérologie Expérimentale, Bruxelles, Belgium.

Mangupli, R.* , Rostomyan, L.* , CASTERMANS, E., CABERG, J.-H., Camperos, P., Krivoy, J., Cuauro, E., BOURS, V., Daly, A., & BECKERS, A. (2016). Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening. Pituitary. doi:10.1007/s11102-016-0732-3
* These authors have contributed equally to this work.

Manard, M., François, S., Bahri, M. A., Phillips, C., BOURS, V., BERTOLI, S., DIDEBERG, V., Salmon, E., & Collette, F. (10 May 2016). The influence of COMT single nucleotide polymorphism (rs4680) on the neural substrates of working memory representations maintenance in healthy aging [Poster presentation]. IUAP Annual meeting.

Potorac, I., CORMAN, V., Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & BECKERS, A. (May 2016). Genetic predisposition to breast cancer occurring in a male-to-female transsexual patient [Poster presentation]. European Congress of Endocrinology, Munich, Germany. doi:10.1530/endoabs.41.EP615

Rostomyan, L., Mangupli, R., CASTERMANS, E., CABERG, J.-H., Camperos, P., Krivoy, J., Cuaruo, E., Bours, V., Daly, A., & BECKERS, A. (May 2016). Combined treatment with octreotide LAR and pegvisomant in patients with gigantism – acromegaly: clinical evaluation and genetic screening [Poster presentation]. European Congress of Endocrinology, Munich, Germany. doi:10.1530/endoabs.41.EP889

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Evrard, B. (April 2016). Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment [Poster presentation]. 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., Rostomyan, L., de Herder, W. W., Naves, L. A., Metzger, D., Cuny, T., Rabl, W., Shah, N. S., Jaffrain-Rea, M.-L., Zatelli, M. C., Faucz, F. R., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... BECKERS, A. (02 March 2016). Somatic mosaicism underlies X-linked acrogigantism (XLAG) syndrome in sporadic male subjects. Endocrine-Related Cancer, 23 (4), 221-233. doi:10.1530/ERC-16-0082

Potorac, I., Pintiaux, A., VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Double genetic defect in a case of congenital hypogonadotropic hypogonadism. In Abstract book - 17th World Congress of Gynecological Endocrinology.

Berendsen, S., Varkila, M., Kroonen, J., Seute, T., Snijders, T. J., Kauw, F., Spliet, W. G. M., Willems, M., Poulet, C., Broekman, M. L., Bours, V., & Robe, P. (2016). Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro-Oncology. doi:10.1093/neuonc/nov238

Castinetti, F.* , Daly, A.* , Stratakis, C., CABERG, J.-H., CASTERMANS, E., Trivellin, G., Rostomyan, L., Saveanu, A., Jullien, N., Reynaud, R., Barlier, A., Bours, V., Brue, T., & Beckers, A. (2016). GPR101 mutations are not a frequent cause of congenital isolated growth hormone deficiency. Hormone and Metabolic Research, 1-5. doi:10.1055/s-0042-100733
* These authors have contributed equally to this work.

CORMAN, V.* , Potorac, I.* , Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & BECKERS, A. (2016). Breast cancer in a male to female transsexual patient with a BRCA2 mutation. Endocrine-Related Cancer, 23 (5), 391-397. doi:10.1530/ERC-16-0057
* These authors have contributed equally to this work.

Daly, A., Lysy, P., Defilles, C., Rostomyan, L., Mohamed, A., CABERG, J.-H., Raverot, V., CASTERMANS, E., Marbaix, E., Maiter, D., Brunelle, C., Trivellin, G., Stratakis, C. A., BOURS, V., Raftopoulos, C., Beauloye, V., Barlier, A., & BECKERS, A. (2016). Growth hormone releasing hormone excess and blockade in X-LAG syndrome. Endocrine-Related Cancer. doi:10.1530/ERC-15-0478

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. 28th EORTC-NCI-AACR symposium on "Molecular targets and cancer therapeutics", Munich, Germany.

Dubois, N., Willems, M., Nguyen-Khac, M.-T., Kroonen, J., Goffart, N., Deprez, M., Bours, V., & Robe, P. (2016). Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential. International Journal of Oncology, 48 (6), 2445-52. doi:10.3892/ijo.2016.3490

FRERES, P., PONCIN, A., MOONEN, M., Josse, C., Oury, C., BOURS, V., LANCELLOTTI, P., & JERUSALEM, G. (2016). La cardiotoxicité des traitements anti-cancéreux. Revue Médicale de Liège, 71 (9), 382-387.

Jaspar, M., Manard, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2016). Influence of COMT Genotype on Antero-Posterior Cortical Functional Connectivity Underlying Interference Resolution. Cerebral Cortex, 26, 498-509. doi:10.1093/cercor/bhu188

Josse, C., & Bours, V. (2016). MicroRNAs and Inflammation in Colorectal Cancer. In O. Slaby & G. A. Calin, Non-coding RNAs in Colorectal Cancer (1° éd, pp. 53-69). Switzerland: Springer. doi:10.1007/978-3-319-42059-2_3

Pepermans, X., Mellado, S., Chialina, S., Wagener, M., Gallardo, L., Lande, H., Bordino, W., Baran, D., Bours, V., & Leal, T. (2016). Identification and frequencies of cystic fibrosis mutations in central Argentina. Clinical Biochemistry. doi:10.1016/j.clinbiochem.2015.10.007

Potorac, I., BETEA, D., MALAISE, O., Daniel, S., CASTERMANS, E., Bours, V., Daly, A., & Beckers, A. (2016). Une forme compliquée d'hypercalcémie hypocalciurique familiale. In Abstract book - Symposium "Perspectives in Endocrinology".

Rostomyan, L., Lysy, P., Desfilles, C., Trivellin, G., CABERG, J.-H., Mohamed, A., Raverot, V., Mantovani, G., Naves, L., Cheetham, T., Shah, N. S., Metzger, D., Zatelli, M., Strebkova, N., Mazerkina, N., Lodish, M., Marbaix, E., Maiter, D., Brunelle, C., ... Beckers, A. (2016). The genetic causes of pituitary gigantism. In Abstract book - Symposium "Perspectives in Endocrinology".

Uwineza, A., Hitayezu, J., JAMAR, M., Caberg, J.-H., Murorunkwere, S., Janvier, N., Bours, V., & Mutesa, L. (2016). Cytogenetic Studies of Rwandan Pediatric Patients Presenting with Global Developmental Delay, Intellectual Disability and/or Multiple Congenital Anomalies. Journal of Tropical Pediatrics. doi:10.1093/tropej/fmv065

VALDES SOCIN, H. G., LIBIOULLE, C., Debray, F.-G., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., Burlacu, C., JONAS, C., Maiter, D., T'Sjoen, G., Poppe, K., Brachet, C., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Neuroendocrine phenotype, genetics and hormonal treatment outcome in idiopathic normosmic hypogonadism and Kallman syndrome patients : A multicenter Belgian Study. In Acta Clinical Belgica.

VALDES SOCIN, H. G., Palmeira, L., Burlacu, M., Daly, A., Bours, V., & Beckers, A. (2016). Cancer thyroïdien familial non médullaire : actualités cliniques et génétiques. Revue Médicale de Liège, 71 (12), 557-561.

Vergote, I., Bours, V., Blaumeiser, B., & Baurain, J.-F. (2016). New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes. Facts, Views and Vision in Obgyn, 8 (3), 161-167.

Willems, M., Dubois, N., Musumeci, L., Bours, V., & Robe, P. (2016). IkappaBzeta: an emerging player in cancer. Oncotarget, 7 (40), 66310-66322. doi:10.18632/oncotarget.11624

Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786
* These authors have contributed equally to this work.

CASTERMANS, E., Auriemma, R., Rostomyan, L., SACRE, N., CABERG, J.-H., Bours, V., Daly, A., & Beckers, A. (2015). Etude moléculaire du gène AIP sur plus de 1400 individus atteints d'adénome hypophysaire. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Potorac, I., BETEA, D., MALAISE, O., Daniel, S., CASTERMANS, E., Bours, V., Daly, A., & Beckers, A. (2015). Une forme compliquée d'hypercalcémie hypocalciurique familiale. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Potorac, I., BETEA, D., PETROSSIANS, P., CASTERMANS, E., HAMOIR, E., Labasse, J., Bours, V., Daly, A., & Beckers, A. (2015). Hyperparathyroïdie primaire familiale isolée - corrélation génotype - phénotype des mutations MEN 1? In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

VALDES SOCIN, H. G., Pintiaux, A., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2015). Hypogonadisme hypogonadotrope normosmique familial : identification d'une nouvelle mutation c.1664-2A> T du gène FGFR1. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., Evrard, B., & Piel, G. (08 September 2015). Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma [Poster presentation]. 'From drug development to target drug'- UniGR workshop on Biomedicine, Arlon, Belgium.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., LANCELLOTTI, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouseplatelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., Lancellotti, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouse platelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (17 April 2015). Liposomes entrapping apigenin for the treatment of glioblastoma [Poster presentation]. 2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (14 April 2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma [Poster presentation]. 1st European conference on Pharmaceutics Reims 2015, Reims, France.

Boukerroucha, M., Josse, C., SEGERS, K., El Guendi, S., FRERES, P., JERUSALEM, G., & Bours, V. (26 March 2015). BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer, 15, 181. doi:10.1186/s12885-015-1205-1

BULK, S., Decortis, T., Rondia, G., CABERG, J.-H., & Bours, V. (06 March 2015). A tale of two anomalies. A paternal duplication and a maternal deletion of 15q13 [Poster presentation]. 15th Belgium Society of Human Genetics Meeting, Charleroi, Belgium.

SEGERS, K., BYNENS, A., & Bours, V. (06 March 2015). From Sanger to NGS : a rapid, cheap, easy and efficient move to next generation sequencing [Poster presentation]. 15th Belgium Society of Human Genetics Meeting, Charleroi, Belgium.

Daly, A., Lodish, M., Trivellin, G., Rostomyan, L., Faucz, F., Yuan, B., Naves, L. A., Choong, C., Lysy, P., Shah, N. S., Verrua, E., CABERG, J.-H., CASTERMANS, E., Zatelli, C., Schernthaner-Reiter, M., Villa, C., Metzger, D., Strebkova, N., Mazerkina, N., ... Beckers, A. (2015). Disease characteristics of patients with X-linked acrogigantism (X-LAG) syndrome. In Abstract book - ENDO 2015.

Lysy, P., Daly, A., Brunelle, C., CABERG, J.-H., Sznajer, Y., Gruson, D., Marbaix, E., BOURS, V., Maiter, D., Beckers, A., & Beauloye, V. (2015). Congenital gigantism in a girl with anterior pituitary hyperplasia : a new genes for a new disease. In Abstract book - 43ème Congrès Annuel de la Société Belge de Pédiatrie.

Stratakis, C., Trivellin, G., Rostomyan, L., Lodish, M., Faucz, F., Naves, L. A., Choong, C., Lysy, P., Shah, N. S., Verrua, E., CABERG, J.-H., CASTERMANS, E., JAMAR, M., Zatelli, M., Schernthaner-Reiter, M., Villa, C., Metzger, D., Strebkova, N., Mazerkina, N., ... Beckers, A. (2015). X-Linked acro-gigantism (X-LAG) syndrome : a new form of infant-onset pituitary gigantism. In Abstract book - 14th International Pituitary Congress.

Trivellin, G., Daly, A., Faucz, F., Yuan, B., Rostomyan, L., Larco, D., Schernthaner-Reiter, M., Szarek, E., Leal, L., CABERG, J.-H., CASTERMANS, E., Villa, C., Dimopoulos, A., Chittiboina, P., Xekouki, P., Shah, N. S., Metzger, D., Lysy, P., Ferrante, E., ... Stratakis, C. (2015). X-Linked acro-gigantism (X-LAG) due to microduplications of chromosome Xq26 : A new disorder and implications for acromegaly. In Abstract book - ENDO 2015.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Thiry, M., Compère, P., BOURS, V., Lancellotti, P., & Oury, C. (27 January 2015). Bacterial DNA mimetics activate platelets and promote thrombosis via CLEC-2 [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Artesi, M., Kroonen, J., Bredel, M., Nguyen-Khac, M., Deprez, M., SCHOYSMAN, L., Poulet, C., Chakravarti, A., Kim, H., Scholtens, D., Seute, T., ROGISTER, B., BOURS, V., & Robe, P. (2015). Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro-Oncology. doi:10.1093/neuonc/nou215

Beckers, A.* , Lodish, M.* , Trivellin, G., Rostomyan, L., Lee, M., Faucz, F., Yuan, B., Choong, C., CABERG, J.-H., Verrua, E., Naves, L. A., Cheetham, T., Young, J., Lysy, P., PETROSSIANS, P., Cotterill, A., Shah, N. S., Metzger, D., CASTERMANS, E., ... Stratakis, C.*. (2015). X-linked acrogigantism syndrome : Clinical Profile and Therapeutic responses. Endocrine-Related Cancer, 22, 353-367. doi:10.1530/ERC-15-0038
* These authors have contributed equally to this work.

Boukerroucha, M., Josse, C., El Guendi, S., Boujemla, B., Freres, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., Jerusalem, G., & Bours, V. (2015). Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers. BMC Cancer, 15 (1), 755. doi:10.1186/s12885-015-1740-9

Boukerroucha, M., Josse, C., El Guendi, S., FRERES, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., JERUSALEM, G., & BOURS, V. (2015). Genetic study of triple negative breast cancers [Poster presentation]. Impakt Breast Cancer Conference, Brussels, Belgium. doi:10.1093/annonc/mdv116.11

Bovy, N., Blomme, B., Freres, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J., Noël, A., Thiry, M., Jerusalem, G., Josse, C., Bours, V., Tabruyn, S., & Struman, I. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. doi:10.18632/oncotarget.3520

DEBRAY, F.-G., Stumpfig, C., Vanlander, A. V., DIDEBERG, V., Josse, C., CABERG, J.-H., BOEMER, F., Bours, V., Stevens, R., Seneca, S., Smet, J., Lill, R., & van Coster, R. (2015). Mutation of the iron-sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy. Journal of Inherited Metabolic Disease. doi:10.1007/s10545-015-9857-1

DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6.

Jaspar, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2015). Modulating effect of COMT Val158Met polymorphism on interference resolution during a working memory task. Brain and Cognition, 95, 7-18. doi:10.1016/j.bandc.2015.01.013

Jaspar, M., DIDEBERG, V., Bours, V., Salmon, E., Maquet, P., & Collette, F. (2015). Modulating effect of COMT Val158Met polymorphism on interference resolution during a working memory task [Poster presentation]. GIGA DAY 2014.

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.

Karim, R., Palazzo, C., Dubois, N., Frère, A., Bours, V., Passirani, C., Evrard, B., & Piel, G. (2015). Design of Liposomes Entrapping Apigenin- A Novel Approach for Glioblastoma Therapy [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Ketelslegers, O., Eyskens, F., BOEMER, F., Bours, V., Minon, J.-M., & Gulbis, B. (2015). Epidemiological data on sickle cell disease in Belgium. Belgian Journal of Hematology, 6 (4), 135-141.

Rostomyan, L.* , Daly, A.* , PETROSSIANS, P., Natchev, E., Lila, A. R., Lecoq, A.-L., Lecumberri Santamaria, B., Trivellin, G., Salvatori, R., Moraitis, A., Holdaway, I., Kranenburg-Van Klaveren, D., Zatelli, M. C., Palacios, N., Nozieres, C., Zacharin, M., Ebeling, T. M. L., Ojaniemi, M., Rozhinskaya, L., ... Beckers, A. (2015). Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocrine-Related Cancer. doi:10.1530/ERC-15-0320
* These authors have contributed equally to this work.

Sticca, T., Wenric, S., CABERG, J.-H., MAX, S., GOTHOT, A., CAERS, J., & Bours, V. (2015). Genomic study of multiple myeloma based on SNP-aCGH and high-throughput exome sequencing.

VALDES SOCIN, H. G., Daly, A., Burlacu, C., CHAVEZ, V., CASTERMANS, E., DIDEBERG, V., HAMOIR, E., BISOGNI, C., BETEA, D., Bours, V., & Beckers, A. (2014). Le cancer thyroïdien papillaire familial (FNMTC): études cliniques et génétiques chez 8 familles. In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014.

FRERES, P., JOSSE, C., Bovy, N., Boukerroucha, M., Struman, I., BOURS, V., & JERUSALEM, G. (2014). Neoadjuvant chemotherapy in breast cancer induces miR-34a and miR-122 expression. Journal of Cellular Physiology. doi:10.1002/jcp.24730

BULK, S., PIERQUIN, G., GAILLEZ, S., GATOT, J.-S., CABERG, J.-H., & Bours, V. (07 February 2014). Evaluation of the distal 22q11 deletion syndrome. A highly variable phenotype [Poster presentation]. 14th Belgium Society of Human Genetics Meeting.

Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019

Jaspar, M., Genon, S., Muto, V., Meyer, C., Manard, M., DIDEBERG, V., BOURS, V., SALMON, E., Maquet, P., & Collette, F. (2014). Modulatory effect of COMT genotype on brain regions underlying proactive control process during inhibition [Poster presentation]. PAI meeting 2014.

Jaspar, M., Genon, S., Muto, V., Meyer, C., Manard, M., DIDEBERG, V., Bours, V., Salmon, E., Maquet, P., & Collette, F. (2014). Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibition. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 50, 148-161. doi:10.1016/j.cortex.2013.06.003

JOSSE, C., Bouznad, N., Geurts, P., Irrthum, A., Huynh-Thu, V. A., Servais, L., Hego, A., Delvenne, P., Bours, V., & Oury, C. (2014). Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 306, 229-43. doi:10.1152/ajpgi.00484.2012

RAMAEKERS, V., Thony, B., Sequeira, J. M., Ansseau, M., Philippe, P., BOEMER, F., Bours, V., & Quadros, E. V. (2014). Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Molecular Genetics and Metabolism, 113 (4), 307-14. doi:10.1016/j.ymgme.2014.10.002

Trivellin, G.* , Daly, A.* , Faucz, F. R., Yuan, B., Rostomyan, L., Larco, D. O., Schernthaner-Reiter, M. H., Szarek, E., Leal, L. F., CABERG, J.-H., CASTERMANS, E., Villa, C., Dimopoulos, A., Chittiboina, P., Xekouki, P., Shah, N. S., Metzger, D., Lysy, P. A., Ferrante, E., ... Stratakis, C. A.*. (2014). Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation. New England Journal of Medicine. doi:10.1056/NEJMoa1408028
* These authors have contributed equally to this work.

Uwineza, A., CABERG, J.-H., Hitayezu, J., JAMAR, M., DIDEBERG, V., Rusingiza, E. K., Bours, V., Mutesa, L., & Hellin, A.-C. (2014). Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies. BMC Medical Genetics, 15 (1), 79. doi:10.1186/1471-2350-15-79

VALDES SOCIN, H. G., Rubio Almanza, M., Tome Fernandez-Ladreda, M., Debray, F.-G., Bours, V., & Beckers, A. (2014). Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Frontiers in Endocrinology, 5, 109. doi:10.3389/fendo.2014.00109

Wenric, S., Freres, P., Josse, C., Bours, V., & Jerusalem, G. (09 December 2013). A miRNA expression based diagnostic tool for breast cancer using random forests [Poster presentation]. Benelux Bioinformatics Conference 2013.

Bothra, N., Daly, A., CASTERMANS, E., Jagtap, V., Buydal, S., Lila, A., Bandgar, T., Rostomyan, L., Potorac, I., BOURS, V., Shah, N., & Beckers, A. (October 2013). FIPA : étude clinique et génétique à l'Hôpital "King Edward Memorial", Bombay (Mumbai) Inde. Annales d'Endocrinologie, 74, 443.

Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffii, A., Stender, J., Balteau, E., DIDEBERG, V., Bours, V., Maquet, P., & Phillips, C. (2013). Altered white matter architecture in BDNF Met carriers. PLoS ONE. doi:10.1371/journal.pone.0069290

Phillips, C., Foret, A., Mascetti, L., Muto, V., Shaffi-Le Bourdiec, A., Stender, J., DIDEBERG, V., BOURS, V., Maquet, P., & Ziegler, E. (19 June 2013). Connectome-based classification of BDNF Met allele carriers [Paper presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States.

JACQUINET, A., CABERG, J.-H., BOURS, V., & DEBRAY, F.-G. (June 2013). Intellectual disability and cancer susceptibility in a family with inherited 14q32.13q32.2 deletion [Poster presentation]. European Society of Human Genetics 2013, Paris, France.

Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffi, A., Stender, J., Balteau, E., DIDEBERG, V., BOURS, V., Maquet, P., & Phillips, C. (June 2013). Connectome-based classification of BDNF Met allele carriers [Poster presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States.

Wenric, S., JOSSE, C., Fasquelle, C., Poulet, C., Sticca, T., Boukerroucha, M., JERUSALEM, G., & Bours, V. (15 March 2013). Exome sequencing of tumors: relevance in copy-number alteration (CNA) analysis and fixed tissue samples [Poster presentation]. 13th Annual Meeting of the Belgian Society of Human Genetics, Bruxelles, Belgium.

Bovy, N., Frères, P., Carnet, O., Bajou, K., Thiry, M., Bours, V., Martial, J., Tabruyn, S. P., & Struman, I. (28 January 2013). The Intercellular Transfer of Endothelial-­‐Circulating-­‐MiR-­‐503 Inhibits Tumor Growth [Paper presentation]. GIGA-Day, Liège, Belgium.

CASTERMANS, E., GAILLEZ, S., & BOURS, V. (2013). Existe-t-il une predisposition genetique aux addictions ? Revue Médicale de Liège, 68 (5-6), 226-32.

Mascetti, L., Foret, A., Schrouff, J., Muto, V., DIDEBERG, V., Balteau, E., Degueldre, C., Phillips, C., Luxen, A., Collette, F., BOURS, V., & MAQUET, P. (2013). Concurrent Synaptic and Systems Memory Consolidation during Sleep. Journal of Neuroscience, 33 (24), 10182-10190. doi:10.1523/JNEUROSCI.0284-13.2013

Uwineza, A., Hitayezu, J., Murorunkwere, S., Ndinkabandi, J., Kalala Malu, C. K., CABERG, J.-H., DIDEBERG, V., BOURS, V., & Mutesa, L. (2013). Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients. Journal of Tropical Pediatrics. doi:10.1093/tropej/fmt090

Uwineza, A., PIERQUIN, G., GAILLEZ, S., JAMAR, M., CABERG, J.-H., & BOURS, V. (2013). Clinical, cytogenetic and molecular characterization of two cases of mosaic ring chromosome 13. Genetic Counseling, 24 (2), 193-200.

Wislet, S.* , Poulet, C.* , Neirinckx, V., Hennuy, B., Swingland, J., Laudet, E., Sommer, L., Shakhova, O., Bours, V., & Rogister, B. (October 2012). In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 7 (10), 46425. doi:10.1371/journal.pone.0046425
* These authors have contributed equally to this work.

Theatre, E., Frederix, K., Guilmain, W., Delierneux, C., Lecut, C., Bettendorff, L., BOURS, V., & Oury, C. (August 2012). Overexpression of CD39 in mouse airways promotes bacteria induced inflammation. Journal of Immunology, 189 (4), 1966-1974. doi:10.4049/jimmunol.1102600

Garraux, G., CABERG, J.-H., Vanbellinghen, J.-F., JAMAR, M., Bours, V., Moonen, G., & DIVE, D. (2012). Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism. Archives of Neurology, 69 (3), 398-400. doi:10.1001/archneurol.2011.802

KROONEN, J.* , Artesi, M.* , CAPRARO, V., Nguyen-Khac, M.-T., Willems, M., Chakravarti, A., Bours, V., & Robe, P. (2012). Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. International Journal of Oncology, 41 (2), 776-82. doi:10.3892/ijo.2012.1489
* These authors have contributed equally to this work.

Lecut, C., Faccinetto, C., Delierneux, C., van Oerle, R., Spronk, H., Evans, R. J., El Benna, J., Bours, V., & Oury, C. (2012). ATP-gated P2X1 ion channels protect from endotoxemia by dampening neutrophil activation. Journal of Thrombosis and Haemostasis, 10 (3), 453-65. doi:10.1111/j.1538-7836.2011.04606.x

LIBIOULLE, C., & BOURS, V. (2012). Les maladies complexes: l'importance de la genetique. Revue Médicale de Liège, 67 (5-6), 220-5.

Mutesa, L., JAMAR, M., PIERQUIN, G., & BOURS, V. (2012). A new 48, XXYY/47, XYY syndrome associated with multiple skeletal abnormalities, congenital heart disease and mental retardation. Indian Journal of Human Genetics, 18 (3), 352-5. doi:10.4103/0971-6866.108033

SCHEEN, A., & Bours, V. (2012). Maladies complexes: des interactions genes-environnement au probleme de sante publique. Revue Médicale de Liège, 67 (5-6), 217-9.

Tichomirowa, M., Lee, M., Barlier, A., Daly, A., Marinoni, I., Jaffrain-Rea, M.-L., Naves, L. A., Rodien, P., Rohmer, V., Faucz, F. R., Caron, P., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Yaneva, M., Guitelman, M., CASTERMANS, E., Verhaege, C., ... Beckers, A. (2012). Cyclin dependent kinase inhibitor (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds. Endocrine-Related Cancer, 19, 233-241. doi:10.1530/ERC-11-0362

Wang, C., Rose-Zerilli, M. J., Koppelman, G. H., Sandling, J. K., Holloway, J. W., Postma, D. S., Holgate, S. T., BOURS, V., Syvanen, A.-C., & Dideberg, V. (2012). Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma. Gene, 504 (2), 220-5. doi:10.1016/j.gene.2012.05.021

SEGERS, K., Debray, F.-G., Wuyts, W., Benoit, V., & Bours, V. (04 March 2011). Co-Occurence of two rare autosomal recessive syndromes in a young patient [Poster presentation]. 11° Belgian Society of Human Genetics Meeting, Louvain-la-Neuve, Belgium.

BOEMER, F., Cornet, Y., LIBIOULLE, C., SEGERS, K., Bours, V., & SCHOOS, R. (2011). 3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. Clinica Chimica Acta, 412 (15-16), 1476-9. doi:10.1016/j.cca.2011.04.031

COLLIGNON, J., Struman, I., Tabruyn, S., Josse, C., Boukerroucha, M., JERUSALEM, G., & BOURS, V. (2011). Aspects moléculaires du cancer du sein triple négatif et les implications thérapeutiques. Revue Médicale de Liège, 66 (5-6), 393-396.

Jaffrain-Rea, M.-L., Daly, A., Angelini, M., Petrossians, P., Bours, V., & Beckers, A. (2011). Genetic susceptibility in pituitary adenomas : from pathogenesis to clinical implications. Expert Review of Endocrinology and Metabolism. doi:10.1586/eem.10.87

Kroonen, J., Nassen, J., Boulanger, Y.-G., Provenzano, F., Capraro, V., Bours, V., Martin, D., Deprez, M., Robe, P., & Rogister, B. (2011). Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. International Journal of Cancer, 129 (3), 574-585. doi:10.1002/ijc.25709

Lecut, C., Faccinetto, C., Evans, R. J., BOURS, V., & Oury, C. (2011). Lack of P2X1 ion channels increases endotoxemia associated coagulation and organ damage through neutrophil hyperresponsiveness. Journal of Thrombosis and Haemostasis, 9 (suppl S2).

Tichomirowa, M. A.* , Barlier, A.* , Daly, A.* , Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., PETROSSIANS, P., Elenkova, A., Tabarin, A., Desailloud, R., Maiter, D., Schurmeyer, T., Cozzi, R., Theodoropoulou, M., Sievers, C., Bernabeu, I., Naves, L. A., Chabre, O., ... Beckers, A. (2011). High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology, 165 (4), 509-15. doi:10.1530/EJE-11-0304
* These authors have contributed equally to this work.

Yaneva, M., Elenkova, A., Daly, A., Tichomirova, M., Bours, V., Kirilov, G., Atanasova, I., Marinov, M., Beckers, A., & Zacharieva, S. (2011). Genetic screening for AIP mutations in Young patients with sporadic and Familial Pituitary Macroadenomas. Endocrinologia, 16 (1), 41-48. doi:10.1038/nrendo.2011.137

Mascetti, L., Foret, A., Matarazzo, L., Muto, V., Balteau, E., Phillips, C., Degueldre, C., Luxen, A., DIDEBERG, V., Bours, V., & Maquet, P. (15 November 2010). Influence of brain-derived neurotrophic factor val66met human polymorphism on declarative memory consolidation [Poster presentation]. Society for Neuroscience, San Diego, United States.

SEGERS, K., Hanson, J., RAMAEKERS, V., & Bours, V. (02 November 2010). Molecular analysis of the FOLR genes in patients with cerebral folate deficiency [Poster presentation]. 60° American Society of Human Genetics Meeting.

Poulet, C., Hennuy, B., Robe, P., Deprez, M., HERENS, C., & Bours, V. (01 November 2010). Subclassification of diffuse glioma tumours based on gene expression and allele copy number variation [Poster presentation]. 12th EUROPEAN WORKSHOP ON CYTOGENETICS AND MOLECULAR GENETICS OF SOLID TUMORS.

Mascetti, L., Foret, A., Matarazzo, L., Muto, V., DIDEBERG, V., Bours, V., & Maquet, P. (15 September 2010). Influence of Brain-Derived Neurotrophic Factor val66met human polymorphism on declarative memory consolidation during sleep. Journal of Sleep Research, 19 (s2).

Beckers, A., Tichomirowa, M., Pellegata, N., Barlier, A., Daly, A., Lee, M., Marinoni, I., Theodoropoulou, M., Verhaeghe, C., Tabarin, A., Rodien, P., Naves, L., Jaffrain-Rea, M. L., Rohmer, V., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Thonnard, A.-S., ... Bours, V. (September 2010). Recherche de la mutation du gène CDKN1B dans les adénomes hypophysaires familiaux isolés (FIPA): analyse de 86 familles. Annales d'Endocrinologie, 71 (5), 398.

Beckers, A., Tichomirowa, M., Pellegata, N., Barlier, A., Daly, A., Lee, M., Marinoni, I., Theodoropoulou, M., Verhaeghe, C., Tabarin, A., Rodien, P., Naves, L., Jaffrain-Rea, M.-L., Rohmer, V., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Thonnard, A.-S., ... Bours, V. (2010). Recherche de la mutation du gène CDKN1B dans les adénomes hypophysaires familiaux isolés (FIPA) : analyse de 86 familles. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Tichomirowa, M. A., Barlier, A., Daly, A., Jaffrain-Rea, M.-L., Tabarin, A., Ronchi, C., Naves, L. A., Cozzi, R., Yaneva, M., Elenkova, A., Maiter, D., Caron, P., Bernabeu, I., Montanana, C. F., Sievers, C., Cogne, M., Corman, V., Halaby, G., Chabre, O., ... Beckers, A. (2010). High Prevalence of AIP Gene Mutations Following Focussed Screening in Young Patients with Sporadic Pituitary Macroadenomas. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Tichomirowa, M. A., Pellegata, N. S., Barlier, A., Daly, A., Lee, M., Marinoni, I., Theodoropoulou, M., Verhaeghe, C., Rodien, P., Naves, L. A., Jaffrain-Rea, M.-L., Rohmer, V., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Yaneva, M., Wemeau, J. L., Tabarin, A., ... Beckers, A. (2010). Cyclin dependent kinase inhibitor 1B (CDKN1B) gene mutations in FIPA. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Josse, C., Schoemans, R., Niessen, N.-A., Delgaudine, M., Hellin, A.-C., Herens, C., Delvenne, P., & Bours, V. (August 2010). Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells. Stem Cells and Development, 19 (8), 1167-1173. doi:10.1089/scd.2009.0264

Stratakis, C. A., Tichomirowa, M. A., Boikos, S., Azevedo, M. F., Lodish, M., Martari, M., Verma, S., Daly, A., Raygada, M., Keil, M. F., Papademetriou, J., Drori-Herishanu, L., Horvath, A., Tsang, K. M., Nesterova, M., Franklin, S., Vanbellinghen, J.-F., Bours, V., Salvatori, R., & Beckers, A. (2010). The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clinical Genetics. doi:10.1111/j.1399-0004.2010.01406.x

Daly, A., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raapana, A., Cazabat, L., De Menis, E., Montanana, C. F., Raverot, G., Weil, R. J., Sane, T., Maiter, D., Neggers, S., Yaneva, M., ... Beckers, A. (2010). Clinical characteristics and therapeutic responses in patients with Germ-line AIP mutations and pituitary adenomas : An international collaborative study. Journal of Clinical Endocrinology and Metabolism, 95 (11). doi:10.1210/jc.2009-2556

DELVENNE, P., Deprez, M., BISIG, B., JAMAR, M., Boniver, J., Bours, V., & HERENS, C. (2010). Fish and chips. Revue Médicale de Liège, 65 Spec no., 3-10.

Schoemans, R., Aigrot, M.-S., Wu, C., Marée, R., Hong, P., Belachew, S., Josse, C., Lubetzki, C., & Bours, V. (2010). Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. Journal of Inherited Metabolic Disease, 33 (2), 113-20. doi:10.1007/s10545-010-9052-3

VALDES SOCIN, H. G., Debray, F.-G., Parent, A.-S., Lebrethon, M.-C., Bourguignon, J.-P., Bours, V., & Beckers, A. (2010). Comment j'EXPLORE ... un hypogonadisme hypogonadotrope congenital isole. Revue Médicale de Liège, 65 (11), 634-41.

Tichomirova, M., Daly, A., Jaffrain-Réa, M. L., Yaneva, M., Zaccharieva, S., Cozzi, R., Sievers, C., Stalla, G., Vanbellinghen, J.-F., Bours, V., & Beckers, A. (2009). High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas. In 52 Symposium der Deutschen Gesellschaft für Endokrinologie.

Tichomoriva, M., Barlier, A., Daly, A., Naves, L., Rodien, P., Bours, V., Pellegata, N., & Beckers, A. (2009). Cyclin dependant kinase inhibitor 1B (CDKN1B) gene mutations in familial isolated pituitary adenomas (FIPA) : Analysis in 86 families. In 52 Symposium der Deutschen Gesellschaft für Endokrinologie.

Beckers, A., Apetrii, P., Daly, A., Tichomirova, M., Vanbellinghen, J.-F., Georges, M., & Bours, V. (2009). Caractérisation clinique et génétique des adénomes hypophysaires familiaux isolés (FIPA). Revue Médicale de Liège, 64 (S1), 15-19.

Boemer, F., Bours, V., Schoos, R., Hubert, P., & Rozet, E. (2009). Analytical validation based on total error measurement and cut-off interpretation of a neonatal screening TSH-immunoassay. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 877, 2412-2417. doi:10.1016/j.jchromb.2008.11.004

Fajardo Montanana, C., Daly, A., Tichomirova, M. A., Vanbellinghen, J.-F., Jaffrain-Réa, M. L., Trescoli Serrano, C., Riesgo Suarez, P., Gomez Vela, J., Tenes, S., Bours, V., & Beckers, A. (2009). TSH-secreting pituitary adenoma in a male patient with a novel missense AIP mutation. In The Endocrine Society's 91st Annual Meeting : 10-13 juin 2009, Washington.

Garraux, G., VANBELLINGHEN, J.-F., JAMAR, M., BOURS, V., Moonen, G., & DIVE, D. (2009). De novo interstitial duplication 4q associated with sporadic young-onset dopa-responsive parkinsonism. Movement Disorders, 24 (Suppl. 1), 138-S139.

Lecut, C., Frederix, K., Johnson, D. M., Deroanne, C., Thiry, M., Faccinetto, C., Marée, R., Evans, R. J., Volders, P. G., Bours, V., & Oury, C. (2009). P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation. Journal of Immunology. doi:10.4049/jimmunol.0804007

Mutesa, L., Azad, A. K., Verhaeghe, C., Segers, K., Vanbellinghen, J.-F., Ngendahayo, L., Rusingiza, E. K., Mutwa, P. R., Rulisa, S., Koulischer, L., Cassiman, J.-J., Cuppens, H., & Bours, V. (2009). Genetic Analysis of Rwandan Patients With Cystic Fibrosis-Like Symptoms: Identification of Novel Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel Gene Variants. CHEST, 135 (5), 1233-42. doi:10.1378/chest.08-2246

Mutesa, L., & Bours, V. (2009). Diagnostic challenges of cystic fibrosis in patients of African origin. Journal of Tropical Pediatrics, 55 (5), 281-6. doi:10.1093/tropej/fmp064

Mutesa, L., Vanbellinghen, J.-F., Hellin, A.-C., Segers, K., Jamar, M., Pierquin, G., & Bours, V. (2009). Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome. Genetic Counseling, 20 (1), 9-17.

Renert, A.-F., Leprince, P., Dieu, M., Renaut, J., Raes, M., Bours, V., Chapelle, J.-P., Piette, J., Merville, M.-P., & Fillet, M. (2009). The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. Journal of Proteome Research, 8 (10), 4810-22. doi:10.1021/pr9005316

Robe, P., Martin, D., Nguyen-Khac, M.-T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009). Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer, 9, 372. doi:10.1186/1471-2407-9-372

Theatre, E., Bours, V., & Oury, C. (2009). A P2X Ion Channel-triggered NF-{kappa}B Pathway Enhances TNF-{alpha}-induced IL-8 Expression in Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. doi:10.1165/rcmb.2008-0452OC

Tichomirova, M. A., Daly, A., Barlier, A., Jaffrain-Réa, M. L., Zacharieva, S., Elenkova, A., Yaneva, M., Naves, L., Cozzi, R., Fajardo Montanana, C., Bernabeu Moron, I., Ronchi, C., Spada, A., Sievers, C., Stalla, G. K., Halaby, G., Vanbellinghen, J.-F., Bours, V., & Beckers, A. (2009). High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas. In The Endocrine Society's 91st Annual Meeting : 10-13 juin 2009, Washington.

Tichomirova, M. A., Daly, A., Pujol, J., Naves, L., Rodien, P., Vanbellinghen, J.-F., Jaffrain-Rea, M.-L., Rohmer, V., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Yaneva, M., Zacharieva, S., Wemeau, J. L., Vantyghem, M. C., Cicarelli, E., Colao, A., Ferrola, P., ... Beckers, A. (2009). An analysis of the role of cyclin dependant kinase inhibitor 1B (CDKN1B) gene mutations in 86 families with familial isolated pituitary adenomas (FIPA). In The Endocrine Society's 91st Annual Meeting : 10-13 juin 2009, Washington.

Apetrii, P., Tikhomirova, M., Daly, A., Fajardo, C., Guitelman, M., Bours, V., Barlier, A., & Beckers, A. (2008). Cyclin dependant kinase inhibitor 1B (CDKN1B) gene mutations in familial isolated pituitary adenomas (FIPA) : Analysis in 84 families. In 18th Meeting of the Belgian Endocrine and Metabolic societies : Bruxelles, 25 octobre 2008.

Tikhomirova, M., Daly, A., Jaffrain-Rea, M.-L., Naves, L. A., Barlier, A., Ferrandez Longas, A., Bours, V., Aaltonen, L. A., & Beckers, A. (2008). An international, collaborative study of disease characteristics and response to therapy in 60 pituitary adenoma patients with Aryl Hydrocarbon Receptor Interacting. In 18th Meeting of the Belgian Endocrine and Metabolic societies : Bruxelles, 25 octobre 2008.

Ansaneli Naves, L., Ferreira Azevedo, M., Faria de Castro, L., Magalhães Gonzaga, M., Augusto Casulari, L., Cunha Vencio, S. A., Daly, A., Tichomirowa, M. A., Vanbellinghen, J.-F., Bours, V., & Beckers, A. (2008). Genetic Causes of Pituitary Adenmas; Focus on the Roe of AIF Status in Multiple Tumor Types. In ENDO 2008: 90th Annual Meeting of the Endocrine Society - Abstract book (pp. 323 (P1-561).

Beckers, A., Vanbellinghen, J.-F., Boikos, S., Martari, M., Verma, S., Daly, A., Raygada, M., Kei, M. F., Papademetriou, J., Drori-Herishanu, L., Horvath, A., Nesterova, M., Tichomirova, M. A., Bours, V., Marx, S., Agarwal, S. K., Salvatori, R., & Stratakis, C. A. (2008). Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features. In ENDO 2008: 90th Annual Meeting of the Endocrine Society - Abstract book (pp. 142 (OR38-1).

Boemer, F., Ketelslegers, O., Minon, J.-M., Bours, V., & Schoos, R. (2008). Newborn Screening for Sickle Cell Disease Using Tandem Mass Spectrometry. Clinical Chemistry, 54 (12), 2036-2041. doi:10.1373/clinchem.2008.106369

Daly, A., Tichomirowa, M. A., Ebeling, T. M. L., Vierimaa, O., Cazabat, L., Jaffrain-Rea, M.-L., Naves, L. A., Eloranta, E., Salmela, P. I., Vanbellinghen, J.-F., Yaneva, M., Zacharieva, S., Barlier, A., Emy, P., Mura, A., Popelier, M., Fajardo, M. C., Sabate, M. I., Guitelman, M., ... Beckers, A. (2008). An International, Collaborative Study of the Disease Characteristics and Response to Therapy in 60 Pituitary Adenoma Patients with Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations. In ENDO 2008: 90th Annual Meeting of the Endocrine Society - Abstract book (pp. 91 (OR8-4).

Fajardo Montanaña, C., Daly, A., Tichomirowa, M. A., Vanbellinghen, J.-F., Theororopoulou, M., Trescoli Serrano, C., Riesgo Suarez, P., Gomez Vela, J., Hagelstein, M.-T., Bours, V., & Beckers, A. (2008). Occurrence of AIP Mutations in Sporidic Pituitary Adenomas and Familial Isolated Pituitary Adenomas Kindreds in Valencia, Spain. In ENDO 2008: 90th Annual Meeting of the Endocrine Society - Abstract book (pp. 803 (P3-775).

Lecut, C., Frederix, K., Johnson, D., Faccinetto, C., Volders, P., Bours, V., & Oury, C. (2008). Contribution of ATP-gated P2X1 ion channels to the control of neutrophil chemotaxis. Purinergic Signalling, 4, 30.

Mutesa, L., Pierquin, G., Janin, N., Segers, K., Thomee, C., Provenzi, M., & Bours, V. (2008). Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genetics and Cytogenetics, 182 (1), 40-2. doi:10.1016/j.cancergencyto.2007.12.005

Mutesa, L., Pierquin, G., Segers, K., Vanbellinghen, J.-F., Gahimbare, L., & Bours, V. (2008). Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. Journal of Tropical Pediatrics, 54 (5), 350-2. doi:10.1093/tropej/fmn034

Reenaers, C., Franchimont, N., Oury, C., Belaiche, J., Malaise, M., Bours, V., Theatre, E., Delvenne, P., & Louis, E. (2008). Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. Scandinavian Journal of Gastroenterology, 43, 1334-1345. doi:10.1080/00365520802200010

Theatre, E., Bours, V., & Oury, C. (2008). Airway P2X ion channels mediate IL-8 expression through CaMKII-dependent NF-kappaB activation. Purinergic Signalling.

Theatre, E., de Leval, L., Bettendorff, L., Bours, V., & Oury, C. (2008). Overexpression of airway CD39 in transgenic mice enhances lipopolysaccharide-induced inflammation. Purinergic Signalling, 4, 113.

Yaneva, M., Daly, A., Tichomirowa, M. A., Vanbellinghen, J.-F., Hagelstein, M.-T., Bours, V., Zacharieva, S., & Beckers, A. (2008). Aryl Hydrocarbon Receptor interacting Protein Gene Mutations in Bulgarian FIPA and Young Sporadic Pituitary Adenoma Patients. In ENDO 2008: 90th Annual Meeting of the Endocrine Society - Abstract book (pp. 735 (P3-520).

Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A. C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., & Syvanen, A. C. (15 December 2007). An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Molecular Genetics, 16 (24), 3008-3016. doi:10.1093/hmg/ddm259

Mutesa, L., Muganga, N., Lissens, W., Boemer, F., Schoos, R., Pierquin, G., & Bours, V. (December 2007). Molecular Analysis in Two Siblings African Patients with Severe Form of Hunter Syndrome: Identification of a Novel (P.Y54x) Nonsense Mutation. Journal of Tropical Pediatrics, 53 (6), 434-7. doi:10.1093/tropej/fmm056

SEGERS, K., MATHIAS, V., GAILLEZ, S., & Bours, V. (23 October 2007). Identification of a point mutation associated with SMA by direct sequencing of genomic DNA [Poster presentation]. 57° American Society of Human Genetics Meeting, San Diego, United States - California.

Naves, L. A., Daly, A., Vanbellinghen, J.-F., Casulari, L. A., Spilioti, C., Magalhaes, A. V., Azevedo, M. F., Giacomini, L. A., Nascimento, P. P., Nunes, R. O., Rosa, J. W. C., Jaffrain-Rea, M.-L., Bours, V., & Beckers, A. (October 2007). Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology, 157 (4), 383-391. doi:10.1530/EJE-07-0533

Lambert, F., Heimann, P., Herens, C., Chariot, A., & Bours, V. (July 2007). Consultations in molecular diagnostics - A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint. Journal of Molecular Diagnostics, 9 (3), 414-419. doi:10.2353/jmoldx.2007.060196

Verhaeghe, C., Delbecque, K., de Leval, L., Oury, C., & Bours, V. (July 2007). Early inflammation in the airways of a cystic fibrosis foetus. Journal of Cystic Fibrosis, 6 (4), 304-308. doi:10.1016/j.jcf.2006.12.001

Verhaeghe, C., Remouchamps, C., Hennuy, B., Vanderplasschen, A., Chariot, A., Tabruyn, S. P., Oury, C., & Bours, V. (15 June 2007). Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochemical Pharmacology, 73 (12), 1982-1994. doi:10.1016/j.bcp.2007.03.019

Daly, A., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., Raverot, G., Barlier, A., De Herder, W., Penfornis, A., Ciccarelli, E., Estour, B., Lecomte, P., Gatta, B., Chabre, O., ... Beckers, A. (May 2007). Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism, 92 (5), 1891-1896. doi:10.1210/jc.2006-2513

Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., De Vos, M., Belaiche, J., Franchimont, D., Van Gossum, A., Louis, E., & Bours, V. (May 2007). The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease. European Journal of Clinical Investigation, 37 (Suppl. 1), 79.

Mutesa, L., Pierquin, G., Cwiny-Ay, N., Buzizi, P., & Bours, V. (March 2007). Le syndrome de Hutchinson-Gilford (progeria): analyse clinique et moleculaire chez une patiente d'origine africaine. Revue Médicale de Liège, 62 (3), 155-8.

Barlier, A., Vanbellinghen, J.-F., Daly, A., Silvy, M., Jaffrain-Rea, M.-L., Trouillas, J., Tamagno, G., Cazabat, L., Bours, V., Brue, T., Enjalbert, A., & Beckers, A. (2007). Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 92 (5), 1952-5. doi:10.1210/jc.2006-2702

Dideberg, V., Louis, E., & Bours, V. (2007). Pharmacogenetics of infliximab in Crohn's disease. Acta Endoscopica, 37 (4), 521-530. doi:10.1007/BF02961799

Faccinetto, C., Lecut, C., Jacobs, N., Bours, V., & Oury, C. (2007). P2X1 receptors as new regulators of neutrophil life span. Journal of Thrombosis and Haemostasis.

Louis, E., Bours, V., Dideberg, V., & Belaiche, J. (2007). Les maladies inflammatoires chroniques intestinales : de la génétique au traitement. Revue Médicale de Liège, 62, 47-51.

Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019
* These authors have contributed equally to this work.

Mutesa, L., Boemer, F., Ngendahayo, L., Rulisa, S., Rusingiza, E., Cwinya-Ay, N., Mazina, D., Kariyo, P., Bours, V., & Schoos, R. (2007). Neonatal screening for sickle cell disease in Central Africa: a study of 1825 newborns with a new enzyme-linked immunosorbent assay test. Journal of Medical Screening, 14 (3), 113-116. doi:10.1258/096914107782066211

Mutesa, L., Hellin, A.-C., Jamar, M., Pierquin, G., Bours, V., & Verloes, A. (2007). Precocious puberty associated with partial trisomy 18q and monosomy 11q. Genetic Counseling, 18 (2), 201-207.

Robe, P., Nguyen-Khac, M.-T., Lambert, F., Lechanteur, C., Jolois, O., Ernst-Gengoux, P., Rogister, B., & Bours, V. (January 2007). Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. International Journal of Oncology, 30 (1), 283-290. doi:10.3892/ijo.30.1.283

Verhaeghe, C., Tabruyn, S., Oury, C., Bours, V., & Griffioen, A. W. (2007). Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochemical and Biophysical Research Communications, 356 (3), 745-749. doi:10.1016/j.bbrc.2007.02.166

Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., Vos, M. D., Belaiche, J., Franchimont, D., Gossum, A. V., Louis, E., & Bours, V. (October 2006). The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease. Pharmacogenetics and Genomics, 16 (10), 727-734. doi:10.1097/01.fpc.0000230117.26581.a4

Benoit, V., de Moraes, E., Dar, N. A., Taranchon, E., Bours, V., Hautefeuille, A., Taniere, P., Chariot, A., Scoazec, J. Y., Gallo, C. V. D., Merville, M.-P., & Hainaut, P. (21 September 2006). Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene, 25 (42), 5708-5718. doi:10.1038/sj.onc.1209579

Close, P., Hawkes, N., Cornez, I., Creppe, C., Lambert, C. A., Rogister, B., Siebenlist, U., Merville, M.-P., Slaugenhaupt, S. A., Bours, V., Svejstrup, J. Q., & Chariot, A. (May 2006). Transcription impairment and cell migration defects in elongator-depleted cells: Implication for familial dysautonomia. Molecular Cell, 22 (4), 521-531. doi:10.1016/j.molcel.2006.04.017

Dideberg, V., Louis, E., Farnir, F., Bertoli, S., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Belaiche, J., & Bours, V. (May 2006). Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study. Pharmacogenetics and Genomics, 16 (5), 369-373. doi:10.1097/01.fpc.0000204993.91806.b1

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479

Chariot, A., Hawkes, N., Cornez, I., Creppe, C., Lambert, C., Rogister, B., Siebenlist, U., Merville, M., Slaugenhaupt, S., Bours, V., Svejstrup, J., & Close, P. (23 March 2006). News from a lost friend: IKAP depletion causes defective transcript elongation of genes involved in cell migration throught NFkB-independent meachanisms: implications for familial dysautonomia [Poster presentation]. Keystone Symposia, Banff, Alberta, Canada.

Boemer, F., Vanbellinghen, J.-F., Bours, V., & Schoos, R. (2006). Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns. Journal of Medical Screening, 13 (3), 132-136. doi:10.1258/096914106778440644

Bonif, M., Meuwis, M.-A., Close, P., Benoit, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M.-P., Piette, J., Beyaert, R., & Chariot, A. (2006). TNFa and IKKb-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKg and NF-kB activation. Biochemical Journal, 394, 593-603. doi:10.1042/BJ20051659

Faccinetto, C., Lecut, C., Greimers, R., Bours, V., & Oury, C. (2006). New role for ATP P2X1 receptors in the control of neutrophil apoptosis and respiratory burst activity. Blood, 108 (11, Part 1), 1647.

Herens, C., Ketelslegers, O., Tassin, F., Hansen, S., & Bours, V. (2006). Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes. Leukemia, 20 (3), 521-2; author reply 522-3. doi:10.1038/sj.leu.2404109

Lambert, F., Schioppa, A., Castermans, S., Lopez, M.-J., Chariot, A., & Bours, V. (2006). Accurate genotyping of the V617F janus kinase (JAK) 2 mutation combining ARMS PCR and capillary electrophoresis. Acta Clinica Belgica, 61 (2, MAR-APR), 108.

Olivier, S., Robe, P., & Bours, V. (2006). Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology, 72 (9), 1054-1068. doi:10.1016/j.bcp.2006.07.023

Relic, B., Benoit, V., Franchimont, N., Kaiser, M.-J., Hauzeur, J.-P., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2006). Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. Journal of Biological Chemistry, 281 (32), 597-604. doi:10.1074/jbc.M512807200

Robe, P., Martin, D., Albert, A., Deprez, M., Chariot, A., & Bours, V. (2006). A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. BMC Cancer, 6, 29. doi:10.1186/1471-2407-6-29

Turkheimer, F. E., Roncaroli, F., Hennuy, B., Herens, C., Nguyen Khac, M.-T., Martin, D., Evrard, A., Bours, V., Boniver, J., & Deprez, M. (2006). Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas. BMC Bioinformatics, 7, 526. doi:10.1186/1471-2105-7-526

Dideberg, V., & Bours, V. (December 2005). Integration de la pharmacogenetique dans la pratique medicale. Revue Médicale de Liège, 60 (12), 918-22.

Close, P., Hawkes, N., Cornez, I., Creppe, C., Lambert, C., Rogister, B., Siebenlist, U., Merville, M., Slaugnhaupt, S., Bours, V., Svejstrup, J., & Chariot, A. (15 November 2005). Elongator depletion causes defective transcript elongation of genes that regulate cell motility [Poster presentation]. Chromatin structure and function, Nassau, Bahamas.

SEGERS, K., Germeau, P., Storm, K., Janin, N., & Bours, V. (25 October 2005). Identification of a nearly complete genomic BRCA1 deletion in six belgian families [Poster presentation]. 55° American Society of Human Genetics Meeting, Salt Lake City, United States - Utah.

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (September 2005). SERMs-induced myeloma cell apoptosis: A study of NF-kappa B inhibition and gene expression signature. Journal of Bone and Mineral Research, 20 (9, Suppl. 1), 213.

Fournier, M., Lacrosse, S., Jamar, M., Bours, V., & Herens, C. (15 July 2005). Deletions of the 3 ' BCR and 5 ' ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells. Cancer Genetics and Cytogenetics, 160 (2), 184-187. doi:10.1016/j.cancergencyto.2005.01.002

Lechanteur, C., Jacobs, N., Greimers, R., Benoit, V., Deregowski, V., Chariot, A., Merville, M.-P., & Bours, V. (03 March 2005). Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis. Oncogene, 24 (10), 1788-1793. doi:10.1038/sj.onc.1208436

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030

Robe, P., Nguyen-Khac, M.-T., Jolois, O., Rogister, B., Merville, M.-P., & Bours, V. (2005). Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. BMC Cancer, 5, 32. doi:10.1186/1471-2407-5-32

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009

Franchimont, N., Reenaers, C., Lambert, C., Belaiche, J., Bours, V., Malaise, M., Delvenne, P., & Louis, E. (December 2004). Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clinical and Experimental Immunology, 138 (3), 491-498. doi:10.1111/j.1365-2249.2004.02643.x

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (December 2004). Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity. Cell Cycle, 3 (12), 1498-1501. doi:10.4161/cc.3.12.1328

Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J. C., Merville, M.-P., Maurer, U., Green, D., Piette, J., Siebenlist, U., Bours, V., & Chariot, A. (08 October 2004). GSK3-Mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular Cell, 16 (1), 35-45. doi:10.1016/j.molcel.2004.09.004

De Seny, D., Fillet, M., Meuwis, M.-A., Lutteri, L., Geurts, P., Wehenkel, L., Bours, V., Piette, J., Malaise, M., & Merville, M.-P. (September 2004). Discovery of new rheumatoid arthritis biomarkers using SELDI-TOF-MS ProteinChip approach. Arthritis and Rheumatism, 50 (9, Suppl. S), 124.

Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Haterte, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., de Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (August 2004). Erratum: Potentiation of tumor necrosis factor-induced NF-κb activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBα (Molecular and Cellular Biology (2003) 23, 17 (6200-6209)). Molecular and Cellular Biology, 24 (15), 6890. doi:10.1128/MCB.24.15.6890.2004

Benoit, V., Relic, B., de Leval, L., Chariot, A., Merville, M.-P., & Bours, V. (February 2004). Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene, 23 (8), 1631-1635. doi:10.1038/sj.onc.1207295

Benoit, V., Chariot, A., Delacroix, L., Deregowski, V., Jacobs, N., Merville, M.-P., & Bours, V. (2004). Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappa B through c-FLIP-L expression. Cancer Research, 64 (8), 2684-2691. doi:10.1158/0008-5472.CAN-03-2914

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2004). The tyrosine kinase inhibitor Imatinib increases irradiation toxicity but does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 19th general meeting of the Belgian Hematological Society, Brussels, Belgium.

Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200

Robe, P., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M.-P., Black, P. M., & Bours, V. (2004). In vitro and in vivo activity of the nuclear factor-kappa B inhibitor sulfasalazine in human glioblastomas. Clinical Cancer Research, 10 (16), 5595-603. doi:10.1158/1078-0432.CCR-03-0392

Robe, P., Jolois, O., Nguyen Khac, M.-T., Princen, Malgrange, B., Merville, M.-P., & Bours, V. (2004). Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. International Journal of Oncology, 25 (1), 187-92. doi:10.3892/ijo.25.1.187

Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J.-L., Piette, J., Bours, V., & Chariot, A. (21 November 2003). Cytoplasmic I kappa B alpha increases NF-kappa B-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. Journal of Biological Chemistry, 278 (47), 46541-46548. doi:10.1074/jbc.M306381200

Herens, C., Radermecker, M., Servais, A.-M., Quatresooz, P., Jardon-Jeghers, C., Bours, V., & de Leval, L. (01 October 2003). Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literature. Cancer Genetics and Cytogenetics, 146 (1), 66-69. doi:10.1016/S0165-4608(03)00098-0

Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Haterte, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., de Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (September 2003). Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Molecular and Cellular Biology, 23 (17), 6200-6209. doi:10.1128/MCB.23.17.6200-6209.2003

Franchimont, N. M., Lambert, C., Ribbens, C., Huynen, P., Relic, B., Bours, V., Merville, M.-P., & Malaise, M. (September 2003). Interleukin-1beta and tumor necrosis factor-alpha enhance the shedding of Interleukin-6 receptor in osteoblastic cells: Involvement of tumor necrosis factor-alpha converting enzyme. Arthritis and Rheumatism, 48 (9, Suppl. S), 482.

Lambert, C., Ribbens, C., Bours, V., Merville, M.-P., Malaise, M., & Franchimont, N. (September 2003). Identification of the signalling pathways required for interleukin-1 beta stimulation of osteoprotegerin synthesis in osteoblastic cells. Journal of Bone and Mineral Research, 18 (Suppl. 2), 142.

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (September 2003). Raloxifene protects Osteoblasts from apoptosis induced by sodium nitroprusside: Potential involvement of ceramide. Journal of Bone and Mineral Research, 18 (Suppl. 2), 136.

Tabruyn, S., Sorlet, C. M., Rentier-Delrue, F., Bours, V., Weiner, R. I., Martial, J., & Struman, I. (September 2003). The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappa B. Molecular Endocrinology, 17 (9), 1815-1823. doi:10.1210/me.2003-0132

Viatour, P., Bentires-Alj, M., Chariot, A., Deregowski, V., de Leval, L., Merville, M.-P., & Bours, V. (July 2003). NF-kappa B2/p100 induces Bcl-2 expression. Leukemia, 17 (7), 1349-1356. doi:10.1038/sj.leu.2402982

Chariot, A., Meuwis, M.-A., Bonif, M., Leonardi, A., Merville, M.-P., Gielen, J.-L., Piette, J., Siebenlist, U., & Bours, V. (April 2003). NF-kappa B activating scaffold proteins as signaling molecules and putative therapeutic targets. Current Medicinal Chemistry, 10 (7), 593-602. doi:10.2174/0929867033457926

Frederich, M., Bentires-Alj, M., Tits, M., Angenot, L., Greimers, R., Gielen, J., Bours, V., & Merville, M.-P. (March 2003). Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells. Journal of Pharmacology and Experimental Therapeutics, 304 (3), 1103-1110. doi:10.1124/jpet.102.044867

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003). NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22, 90-97. doi:10.1038/sj.onc.1206056

Fillet, M., Bentires-Alj, M., Deregowski, V., Greimers, R., Gielen, J.-L., Piette, J., Bours, V., & Merville, M.-P. (2003). Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochemical Pharmacology, 65 (10), 1633-42. doi:10.1016/S0006-2952(03)00125-4

Herens, C., Baron, F., Croisiau, C., Tassin, F., & Bours, V. (2003). Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases. Cancer Genetics and Cytogenetics, 147 (1), 78-80. doi:10.1016/S0165-4608(03)00198-5

Jamar, M., Lemarchal, C., Koulischer, L., Bours, V., & LEMAIRE, V. (2003). A low rate of trisomy 21 in twin-pregnancies: A cytogenetics retrospective study of 278 cases. Genetic Counseling, 14 (4), 395-400.

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 18th general meeting of the Belgian Hematological Society, Brussels, Belgium.

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 32nd annual meeting of the International Society of Experimental Hematology, Paris, France.

Viatour, P., Legrand-Poels, S., Van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., BOURS, V., & Chariot, A. (2003). Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histones deacetylases (HDAC1 and HDAC3). Journal of Biological Chemistry.

Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., de Launoit, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (November 2002). Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappa B and inhibitors of deacetylases: Potential perspectives for the development of therapeutic strategies. Journal of Virology, 76 (21), 11091-11103. doi:10.1128/JVI.76.21.11091-11103.2002

Polus, M., Bours, V., Jerusalem, G., Sautois, B., & Fillet, G. (July 2002). Comment je traite.... Le cancer avance du pancreas par une approche innovante dirigee contre les nouvelles cibles. Revue Médicale de Liège, 57 (7), 428-32.

Bureau, F., Vanderplasschen, A., Jaspar, F., Minner, F., Pastoret, P.-P., Merville, M. P., Bours, V., & Lekeux, P. (May 2002). Constitutive nuclear factor-kappa B activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood, 99 (10), 3683-3691. doi:10.1182/blood.V99.10.3683

Baron, F., Turhan, A. G., Giron-Michel, J., Azzarone, B., Bentires-Alj, M., Bours, V., Bourhis, J. H., Chouaib, S., & Caignard, A. (2002). Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression. Blood, 99 (6), 2107-13. doi:10.1182/blood.V99.6.2107

Delhalle, S., Deregowski, V., Benoit, V., Merville, M.-P., & Bours, V. (2002). NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene, 21 (24), 3917-24. doi:10.1038/sj.onc.1205489

Deregowski, V., Delhalle, S., Benoit, V., Bours, V., & Merville, M.-P. (2002). Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. Biochemical Pharmacology, 64 (5-6), 873-81. doi:10.1016/S0006-2952(02)01151-6

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2002). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibior STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 44th annual meeting and exposition of American Society of Hematology, Philadelphia, United States.

Relic, B., Bentires-Alj, M., Ribbens, C., Franchimont, N., Guerne, P.-A., Benoit, V., Merville, M.-P., Bours, V., & Malaise, M. (2002). TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Laboratory Investigation, 82 (12), 1661-1672. doi:10.1097/01.LAB.0000041714.05322.C0

De Leval, X., David, J. L., Neven, P., Benoit, V., Pirotte, B., Merville, M.-P., Bours, V., & Dogne, J. M. (December 2001). Effects of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, on osteogenic sarcoma cell-induced platelet aggregation [Poster presentation]. The 43rd ASH Annual Meeting, Orlando, United States.

de Leval, X., David, J.-L., Neven, P., Benoit, V., Pirotte, B., Merville, M.-P., Bours, V., & Dogné, J.-M. (16 November 2001). Effects of BM-573, a dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor, on osteogenic sarcoma cell-induced platelet aggregation. Blood, 98 (11, Part 2), 43.

Fievez, L., Kirschvink, N., Dogne, S., Jaspar, F., Merville, M.-P., Bours, V., Lekeux, P., & Bureau, F. (01 September 2001). Impaired Accumulation of Granulocytes in the Lung During Ozone Adaptation. Free Radical Biology and Medicine, 31 (5), 633-641. doi:10.1016/S0891-5849(01)00621-9

Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J. C., Merville, M.-P., & Bours, V. (11 May 2001). Inhibition of the Nf-Kappa B Transcription Factor Increases Bax Expression in Cancer Cell Lines. Oncogene, 20 (22), 2805-13. doi:10.1038/sj.onc.1204343

Verlaet, M., Deregowski, V., Denis, G., Humblet, C., Stalmans, M.-T., Bours, V., Castronovo, V., Boniver, J., & Defresne, M.-P. (27 April 2001). Genetic Imbalances in Preleukemic Thymuses. Biochemical and Biophysical Research Communications, 283 (1), 12-8. doi:10.1006/bbrc.2001.4731

Princen, F., Robe, P., Gros, D., Jarry-Guichard, T., Gielen, J., Merville, M.-P., & Bours, V. (March 2001). Rat Gap Junction Connexin-30 Inhibits Proliferation of Glioma Cell Lines. Carcinogenesis, 22 (3), 507-13. doi:10.1093/carcin/22.3.507

Bureau, F., Vanderplasschen, A., Jaspar, F., Minner, F., Pastoret, P.-P., Merville, V., Bours, V., & Lekeux, P. (2001). Constitutive NF-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. In Proceedings: International Symposium: NF-kappaB: Regulation, Gene Expression & Disease.

Detry, O., Detroz, B., Preud'Homme, L., Bours, V., Honore, P., & Jacquet, N. (January 2001). Radiofrequency ablation of liver tumors: short term evaluation. Acta Gastro-Enterologica Belgica, 64 (1), 11.

Fievez, L., Kirschvink, N., Dogné, S., Jaspar, F., Merville, M. P., Bours, V., Lekeux, P., & Bureau, F. (2001). Ozone adaptation in calves is associated with impaired accumulation of granulocytes in the lung. In Proceedings: Comparative Respiratory Society Meeting (pp. 62). Comparative Respiratory Society Meeting.

Mami-Chouaib, F., Ameyar, M., Dorothee, G., Bentires-Alj, M., Dziembowska, M., Delhalle, S., Gay, F., Stancou, R., Bours, V., & Chouaib, S. (2001). Effect of nuclear factor kappaB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic function. European Journal of Immunology, 31 (2), 433-9. doi:10.1002/1521-4141(200102)31:2<433::AID-IMMU433>3.0.CO;2-T

Hellin, A.-C., Bentires-Alj, M., Verlaet, M., Benoit, V., Bours, V., & Merville, M.-P. (December 2000). Roles of Nuclear Factor-Kappab, P53, and P21/Waf1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis. Journal of Pharmacology and Experimental Therapeutics, 295 (3), 870-8.

Bours, V., Bonizzi, G., Bentires-Alj, M., Bureau, F., Piette, J., Lekeux, P., & Merville, M.-P. (16 November 2000). Nf-Kappab Activation in Response to Toxical and Therapeutical Agents: Role in Inflammation and Cancer Treatment. Toxicology, 153 (1-3), 27-38. doi:10.1016/S0300-483X(00)00302-4

Bureau, F., Delhalle, S., Bonizzi, G., Fievez, L., Dogne, S., Kirschvink, N., Vanderplasschen, A., Merville, M.-P., Bours, V., & Lekeux, P. (15 November 2000). Mechanisms of Persistent Nf-Kappa B Activity in the Bronchi of an Animal Model of Asthma. Journal of Immunology, 165 (10), 5822-5830. doi:10.4049/jimmunol.165.10.5822

Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., & Merville, M.-P. (15 October 2000). Nuclear Factor-Kappa B, Cancer, and Apoptosis. Biochemical Pharmacology, 60 (8), 1085-9. doi:10.1016/S0006-2952(00)00391-9

Benoit, V., Hellin, A.-C., Huygen, S., Gielen, J., Bours, V., & Merville, M.-P. (28 September 2000). Additive Effect between Nf-Kappab Subunits and P53 Protein for Transcriptional Activation of Human P53 Promoter. Oncogene, 19 (41), 4787-94. doi:10.1038/sj.onc.1203831

Robe, P., Rogister, B., Merville, M.-P., & Bours, V. (11 September 2000). Growth Regulation of Astrocytes and C6 Cells by Tgfbeta1: Correlation with Gap Junctions. Neuroreport, 11 (13), 2837-41. doi:10.1097/00001756-200009110-00003

Lechanteur, C., Delvenne, P., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J., Merville, M.-P., & Bours, V. (September 2000). Combined Suicide and Cytokine Gene Therapy for Peritoneal Carcinomatosis. Gut, 47 (3), 343-8. doi:10.1136/gut.47.3.343

Robe, P., Princen, F., Martin, D., Malgrange, B., Stevenaert, A., Moonen, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (15 July 2000). Pharmacological Modulation of the Bystander Effect in the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy System: Effects of Dibutyryl Adenosine 3',5'-Cyclic Monophosphate, Alpha-Glycyrrhetinic Acid, and Cytosine Arabinoside. Biochemical Pharmacology, 60 (2), 241-9. doi:10.1016/S0006-2952(00)00315-4

Gast, P., Bours, V., Detroz, B., Colette, M. Y., & Booz, V. (May 2000). Recommandations en matiere de traitement du cancer rectal. Revue Médicale de Liège, 55 (5), 350-5.

Jerusalem, G., Bours, V., & Fillet, G. (May 2000). Traitement adjuvant du cancer du sein: meta-analyse et recommandations therapeutiques. Revue Médicale de Liège, 55 (5), 356-9.

Lechanteur, C., Moutschen, M., Princen, F., Lopez, M.-J., Franzen, E., Gielen, J., Bours, V., & Merville, M.-P. (May 2000). Antitumoral Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-12-Expressing Dhd/K12 Colon Adenocarcinoma Cells. Cancer Gene Therapy, 7 (5), 676-82. doi:10.1038/sj.cgt.7700152

Bureau, F., Bonizzi, G., Kirschvink, N., Delhalle, S., Desmecht, D., Merville, M. P., Bours, V., & Lekeux, P. (April 2000). Correlation between Nuclear Factor-Kappab Activity in Bronchial Brushing Samples and Lung Dysfunction in an Animal Model of Asthma. American Journal of Respiratory and Critical Care Medicine, 161 (4, Pt 1), 1314-1321. doi:10.1164/ajrccm.161.4.9907010

Jerusalem, G., Bours, V., & Fillet, G. (March 2000). Existe-t-il des progres dans le traitement du cancer du pancreas metastatique? Revue Médicale de Liège, 55 (3), 146-8.

Bentires-Alj, M., Hellin, A.-C., Lechanteur, C., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (January 2000). Cytosine Deaminase Suicide Gene Therapy for Peritoneal Carcinomatosis. Cancer Gene Therapy, 7 (1), 20-6. doi:10.1038/sj.cgt.7700093

Bonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (01 January 2000). Cell Type-Specific Role for Reactive Oxygen Species in Nuclear Factor-Kappab Activation by Interleukin-1. Biochemical Pharmacology, 59 (1), 7-11. doi:10.1016/S0006-2952(99)00290-7

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Bureau, F., Delhalle, S., Bonizzi, G., Fievez, L., Kirschvink, N., Dogné, S., Merville, M.-P., Bours, V., & Lekeux, P. (2000). An autocrine mechanism maintains persistent nuclear factor-kB activation in the bronchi of an animal model of asthma. In Proceedings: International Conference of the American Thoracic Society.

Locigno, R., Antoine, N., Bours, V., Daukandt, M., Heinen, E., & Castronovo, V. (January 2000). Tnp-470, a Potent Angiogenesis Inhibitor, Amplifies Human T Lymphocyte Activation through an Induction of Nuclear Factor-Kappab, Nuclear Factor-at, and Activation Protein-1 Transcription Factors. Laboratory Investigation, 80 (1), 13-21. doi:10.1038/labinvest.3780003

Princen, F., Lechanteur, C., Lopez, M.-J., Gielen, J., Bours, V., & Merville, M.-P. (2000). Similar Efficiency of DNA-Liposome Complexes and Retrovirus-Producing Cells for Hsv-Tk Suicide Gene Therapy of Peritoneal Carcinomatosis. Journal of Drug Targeting, 8 (2), 79-89. doi:10.3109/10611860008996854

Chariot, A., Gielen, J., Merville, M.-P., & Bours, V. (December 1999). The homeodomain-containing proteins: an update on their interacting partners. Biochemical Pharmacology, 58, 1851-1857. doi:10.1016/S0006-2952(99)00234-8

Princen, F., Robe, P., Lechanteur, C., Mesnil, M., Rigo, J.-M., Gielen, J., Merville, M.-P., & Bours, V. (November 1999). A Cell Type-Specific and Gap Junction-Independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-Mediated Bystander Effect. Clinical Cancer Research, 5 (11), 3639-44.

Bentires-Alj, M., Merville, M.-P., & Bours, V. (August 1999). Nf- Kappa B and Chemoresistance: Could Nf- Kappa B Be an Antitumor Target? Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 2 (4), 274-276. doi:10.1054/drup.1999.0093

Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (22 April 1999). Regulation of Nf-Kappab Activity by I Kappab-Related Proteins in Adenocarcinoma Cells. Oncogene, 18 (16), 2567-77. doi:10.1038/sj.onc.1202599

Bonizzi, G., Piette, J., Haterte, S., Merville, M.-P., & Bours, V. (15 March 1999). Role of the Protein Kinase C Lambda/Iota Isoform in Nuclear Factor-Kappab Activation by Interleukin-1beta or Tumor Necrosis Factor-Alpha: Cell Type Specificities. Biochemical Pharmacology, 57 (6), 713-20. doi:10.1016/S0006-2952(98)00353-0

Bonizzi, G., Piette, J., Haterte, S., Greimers, R., Havard, L., Merville, M.-P., & Bours, V. (March 1999). Reactive Oxygen Intermediate-Dependent Nf-Kappab Activation by Interleukin-1beta Requires 5-Lipoxygenase or Nadph Oxidase Activity. Molecular and Cellular Biology, 19 (3), 1950-60. doi:10.1128/mcb.19.3.1950

Bentires-Alj, M., Hellin, A.-C., Ameyar, M., Chouaib, S., Merville, M.-P., & Bours, V. (10 February 1999). Stable Inhibition of Nuclear Factor Kappab in Cancer Cells Does Not Increase Sensitivity to Cytotoxic Drugs. Cancer Research, 59 (4), 811-5.

Chariot, A., Princen, F., Gielen, J., Merville, M.-P., Franzoso, G., Brown, K., Siebenlist, U., & Bours, V. (10 February 1999). Ikappab-Alpha Enhances Transactivation by the Hoxb7 Homeodomain-Containing Protein. Journal of Biological Chemistry, 274 (9), 5318-25. doi:10.1074/jbc.274.9.5318

Bureau, F., Bonizzi, G., Kirschvink, N., Delhalle, S., Winnepenninckx, V., Merville, M.-P., Bours, V., & Lekeux, P. (1999). Sustained NF-kB activity after removal of the etiologic agent in an animal model of asthma. In Proceedings: 1999 International Conference of the American Thoracic Society.

Chariot, A., Van Lint, C., Chapelier, M., Gielen, J., Merville, M.-P., & Bours, V. (1999). CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene, 18, 4007-4012. doi:10.1038/sj.onc.1202776

Jerusalem, G., Bours, V., & Fillet, G. (1999). Actualités thérapeutiques dans le traitement du cancer colorectal. Médecine et Hygiène, 57, 1552-1554.

Matroule, J. Y., Bonizzi, G., Morliere, P., Paillous, N., Santus, R., Bours, V., & Piette, J. (1999). Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. Journal of Biological Chemistry, 274 (5), 2988-3000. doi:10.1074/jbc.274.5.2988

Rezaei Kalantari, H., Jerusalem, G., Bours, V., & Fillet, G. (January 1999). Les tumeurs malignes d'origine indéterminée. Revue Médicale de Liège, 54 (1), 39-42.

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.

Princen, F., Lechanteur, C., Lopez Y Cadenas, M., Rocoux, G., Detroz, B., Gielen, J.-L., Fillet, G., Merville, M.-P., & Bours, V. (August 1998). Repeated Cycles of Retrovirus-Mediated Hsvtk Gene Transfer Plus Ganciclovir Increase Survival of Rats with Peritoneal Carcinomatosis. Gene Therapy, 5 (8), 1054-60. doi:10.1038/sj.gt.3300710

Jerusalem, G., Bours, V., & Fillet, G. (June 1998). Pharma-clinics. Comment je traite... II. Approche thérapeutique du cancer colorectal métastatique. Revue Médicale de Liège, 53 (6), 318-21.

Defechereux-Thibaut de Maisières, P., Baudoux-Tebache, L., Merville, M.-P., Rentier, B., Bours, V., & Piette, J. (May 1998). Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region. Journal of Biological Chemistry, 273 (22), 13636-13644.

Jerusalem, G., Bours, V., & Fillet, G. (May 1998). Traitement du cancer colorectal. Aspects pharmaco-économiques. Revue Médicale de Liège, 53 (5), 276-8.

Bours, V., Jerusalem, G., & Fillet, G. (April 1998). Comment je traite ... Le cancer colorectal: I. Prévention et traitement adjuvant. Revue Médicale de Liège, 53 (4), 167-70.

Hellin, A.-C., Calmant, P., Bours, V., Merville, M.-P., & Gielen, J. (05 March 1998). Nuclear Factor - Kappab-Dependent Regulation of P53 Gene Expression Induced by Daunomycin Genotoxic Drug. Oncogene, 16 (9), 1187-95. doi:10.1038/sj.onc.1201638

Dejardin, E., Deregowski, V., GREIMERS, R., Cai, Z., Chouaib, S., Merville, M.-P., & BOURS, V. (1998). Regulation of major histocompatibility complex class I expression by NF-kB-related proteins in breast cancer cells. Oncogene. doi:10.1038/sj.onc.1201879

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J., Bours, V., & Merville, M.-P. (1998). Hsv-1 Thymidine Kinase Gene Therapy for Peritoneal Carcinomatosis. Advances in Experimental Medicine and Biology, 451, 115-9. doi:10.1007/978-1-4615-5357-1_18

Bonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (01 December 1997). Distinct Signal Transduction Pathways Mediate Nuclear Factor-Kappab Induction by Il-1beta in Epithelial and Lymphoid Cells. Journal of Immunology, 159 (11), 5264-72.

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J.-L., Bours, V., & Merville, M.-P. (November 1997). Hsv-1 Thymidine Kinase Gene Therapy for Colorectal Adenocarcinoma-Derived Peritoneal Carcinomatosis. Gene Therapy, 4 (11), 1189-94. doi:10.1038/sj.gt.3300520

Piette, J., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M.-P., Legrand-Poels, S., & Bours, V. (November 1997). Multiple Redox Regulation in Nf-Kappab Transcription Factor Activation. Biological Chemistry, 378 (11), 1237-45.

Michaux, L., Dierlamm, J., Wlodarska, I., Bours, V., Van den Berghe, H., & Hagemeijer, A. (1997). t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genetics and Cytogenetics, 94 (1), 36-43. doi:10.1016/S0165-4608(96)00247-6

Bonizzi, G., Dejardin, E., Piret, B., Piette, J., Merville, M.-P., & Bours, V. (15 December 1996). Interleukin-1 Beta Induces Nuclear Factor Kappa B in Epithelial Cells Independently of the Production of Reactive Oxygen Intermediates. European Journal of Biochemistry, 242 (3), 544-9. doi:10.1111/j.1432-1033.1996.0544r.x

Hermanne, J.-P., Tassin, F., Bours, V., & Fillet, G. (March 1996). Rétinoïdes et leucémie aigue promyelocytaire. Une révolution thérapeutique. Revue Médicale de Liège, 51 (3), 217-23.

Defechereux, P., Baudoux, L., Merville, M.-P., Bours, V., Rentier, B., & Piette, J. (1996). Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus ORF4 encoded protein involves binding sites for nuclear factor kappa B [Paper presentation]. 21st International Herpesvirus Workshop, De Kalb, Illinois, United States.

Hermanne, J.-P., TASSIN, F., Bours, V., & Fillet, G. (1996). Intérêt de l'acide rétinoïque "tous trans" dans le traitement de la leucémie aiguë promyélocytaire. Médecine et Hygiène, 54, 1472-1479.

Dejardin, E., Bonizzi, G., Bellahcene, A., Castronovo, V., Merville, M.-P., & Bours, V. (02 November 1995). Highly-Expressed P100/P52 (Nfkb2) Sequesters Other Nf-Kappa B-Related Proteins in the Cytoplasm of Human Breast Cancer Cells. Oncogene, 11 (9), 1835-41.

Legrand-Poels, S., Bours, V., Piret, B., Pflaum, M., Epe, B., Rentier, B., & Piette, J. (24 March 1995). Transcription factor NF-kB is activated by photosensitization generating oxidative DNA damages. Journal of Biological Chemistry, 270 (12), 6925-6934. doi:10.1074/jbc.270.12.6925

Antoine, N., Bours, V., Heinen, E., Simar, L. J., & Castronovo, V. (18 January 1995). Simulation of Human B-Lymphocyte Proliferation by Agm-1470, a Potent Inhibitor of Angiogenesis. Journal of the National Cancer Institute, 87 (2), 136-9. doi:10.1093/jnci/87.2.136

Drew, P. D., Franzoso, G., Becker, K. G., Bours, V., Carlson, L. M., Siebenlist, U., & Ozato, K. (1995). NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. Journal of Interferon and Cytokine Research, 15 (12), 1037-45. doi:10.1089/jir.1995.15.1037

Jerusalem, G., Detroz, B., Herman, P., Dohogne, A., Closon, M. T., Jacquet, N., Honoré, P., Bruyninx, L., Fillet, G., Fassotte, M.-F., Bours, V., & Lipcsei, G. (1995). Approche thérapeutique du cancer épithélial de l'ovaire au CHU Sart Tilman : Conclusions de la réunion interdisciplinaire du 22 mars 1995. Revue Médicale de Liège, 50, 469-471.

Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (13 January 1994). The Nf-Kappa B Transcription Factor and Cancer: High Expression of Nf-Kappa B- and I Kappa B-Related Proteins in Tumor Cell Lines. Biochemical Pharmacology, 47 (1), 145-9. doi:10.1016/0006-2952(94)90448-0

Bours, V. (1994). The NF-kappaB transcription factor: structure, function and interaction with the oncoprotein Bcl-3 [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/76661

Bours, V., Azarenko, V., Dejardin, E., & Siebenlist, U. (1994). Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins. Oncogene, 9 (6), 1699-702.

Qian, J., Bours, V., Manischewitz, J., Blackburn, R., Siebenlist, U., & Golding, H. (1994). Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins. Journal of Immunology, 152 (8), 4183-91.

Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K., & Siebenlist, U. (1993). The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell, 72 (5), 729-39. doi:10.1016/0092-8674(93)90401-B

Bressler, P., Brown, K., Timmer, W., Bours, V., Siebenlist, U., & Fauci, A. S. (1993). Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants. Journal of Virology, 67 (1), 288-93. doi:10.1128/jvi.67.1.288-293.1993

Franzoso, G., Bours, V., Azarenko, V., Park, S., Tomita-Yamaguchi, M., Kanno, T., Brown, K., & Siebenlist, U. (1993). The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO Journal, 12 (10), 3893-901. doi:10.1002/j.1460-2075.1993.tb06067.x

Segars, J. H., Nagata, T., Bours, V., Medin, J. A., Franzoso, G., Blanco, J. C., Drew, P. D., Becker, K. G., An, J., & Tang, T. (1993). Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Molecular and Cellular Biology, 13 (10), 6157-69. doi:10.1128/mcb.13.10.6157

Bours, V., Burd, P. R., Brown, K., Villalobos, J., Park, S., Ryseck, R. P., Bravo, R., Kelly, K., & Siebenlist, U. (1992). A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Molecular and Cellular Biology, 12 (2), 685-95. doi:10.1128/mcb.12.2.685

Bours, V., Franzoso, G., Brown, K., Park, S., Azarenko, V., Tomita-Yamaguchi, M., Kelly, K., & Siebenlist, U. (1992). Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Current Topics in Microbiology and Immunology, 182, 411-20. doi:10.1007/978-3-642-77633-5_52

Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., & Siebenlist, U. (1992). The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature, 359 (6393), 339-42. doi:10.1038/359339a0

Ryseck, R. P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., & Bravo, R. (1992). RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Molecular and Cellular Biology, 12 (2), 674-84. doi:10.1128/MCB.12.2.674

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N

Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79.

Bours, V., Villalobos, J., Burd, P. R., Kelly, K., & Siebenlist, U. (1990). Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature, 348 (6296), 76-80. doi:10.1038/348076a0

Beguin, Y., Bours, V., Delbrouck, J. M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (November 1989). Relationship of Serum Selenium Levels to Tumor Activity in Acute Non-Lymphocytic Leukemia. Carcinogenesis, 10 (11), 2089-91. doi:10.1093/carcin/10.11.2089

Fillet, G., Bury, J., Beguin, Y., Duvivier, A., Hoyoux, C., & Bours, V. (1987). Les cancers hématologiques en 1987. Chimiothérapie et immunothérapie. Revue Médicale de Liège, 42 (10), 496-502.